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ABSTRACT OF DISSERTATION 
 
 
EFFECT OF CHRONIC AIRWAY INFLAMMTION INDUCED BY ALLERGEN 
SENSITIZATION ON VAGAL BRONCHOPULMOANRY SENSORY NERVES 
 IN RATS  
 
Airway hyperresponsivness (AHR) is one of most prominent pathophysiological 
features of asthma. Increasing evidence suggests that vagal bronchopulmonary afferents 
may be involved in the development of AHR. However, the underlying mechanisms are 
not clear. Therefore, the purpose of this dissertation was to investigate the effect of 
chronic airway inflammation induced by allergen sensitization on vagal 
bronchopulmonary afferents. The study was carried out in an animal model of allergic 
asthma. Brown-Norway rats were sensitized by intraperitoneal Ovalbumin (Ova) and 
exposed to aerosolized Ova 3 times/week for three weeks. Control rats received the 
vehicle. In vivo single-fiber recording technique was applied in this study. Our results 
showed that chronic Ova exposure caused an elevated baseline activity of pulmonary C-
fibers, and a distinctly higher sensitivity of these afferents to chemical stimulants and 
lung inflation. After an acute Ova inhalation challenge, the increase in baseline activity 
and the excitability of pulmonary C-fibers were further augmented in sensitized rats, but 
not in control rats. In addition, sensitivity of pulmonary myelinated afferents to capsaicin 
was significantly elevated after chronic airway inflammation was induced by allergen. 
Furthermore, immunohistochemsitry data showed that, in nodose ganglia the proportion 
of transient receptor potential vanilloids type 1 channels (TRPV1)-expressing 
bronchopulmonary neurons was significantly higher in sensitized rats than in controls. 
This increase of TRPV1 expression was found mainly in neurofilament-positive neurons 
(myelinated neurons), but this effect was absent in jugular ganglia. In conclusion, 
allergen-induced airway inflammation caused a pronounced sensitizing effect on vagal 
pulmonary non-myelinated (C-fiber) afferents and elevated the sensitivity of vagal 
pulmonary myelinated afferents to capsaicin. The latter was accompanied by the 
upregulation of TRPV1 expression in these myelinated neurons.  
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CHAPTER ONE 
Introduction 
 
1.1 Background 
Asthma 
Asthma is a life-threatening lung disease that causes various problems in 
breathing (e.g., airway obstruction, hypoxia, shortness of breath, coughing etc.). In the 
United States, asthma prevalence has been increasing since the early 1980s in all ages 
and racial groups, and in both sexes. It affects an estimated 14.9 million persons and 
cause over 1.5 million emergency hospital visits, about 500,000 hospitalizations, and 
over 5,500 deaths in 1995. The estimated direct and indirect monetary costs for this 
disease added up to $11.3 billion in 1998 [1]. Therefore, in addition to the high 
prevalence of asthma, asthma remains a major illness in terms of mobility, suffering and 
financially cost. It is very important to understand the pathogenetic mechanisms of 
asthma. 
  Asthma is a disease characterized by episodic and reversible airway obstruction 
and inflammation, accompanied by airway hyperresponsiveness (AHR), which is defined 
as an increased bronchoconstrictive response to bronchial provocative challenge [2]. The 
exact cause of asthma remains uncertain, but, it is known that several factors may 
contribute to the development of this disease, for example, genetic factors (e.g., a history 
of asthma in the family), environmental factors (e.g., air pollution, occupational exposure, 
viral infections and allergen exposure) and life style factors (e.g., smoking). In 
susceptible individuals, asthma causes recurrent episodes of wheezing, breathlessness, 
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chest tightness and coughing [3]. The development of allergic asthma episodes consists 
of three phases, namely the induction phase, the early-phase asthmatic response (EAR), 
and the late-phase asthmatic response (LAR). Each phase is characterized by the 
production and interaction of various cell-derived mediators. In the induction phase, T 
helper (TH) cytokines are important in the development of asthma. Inhaled allergens that 
escape the mucociliary clearance are taken up and processed by antigen presenting cells 
(APCs), which are distributed throughout the respiratory tract, from the nasal mucosa to 
the lung pleura. These APCs then migrate to the  lymph nodes where the processed 
allergen is presented to allergen specific T and B cells [4, 5]. Interactions between those 
cells elicit responses that are influenced by secreted cytokines and cell-bound co-
stimulatory molecules. Activation of TH cells by APCs leads to the production of 
cytokines that regulate the isotype switch of B cells in their production of 
immunoglobulin (Ig) E [4]. Once synthesized, IgE antibodies circulate in the blood 
before binding to the high-affinity IgE receptor FcεRI that is present on mast cells in 
tissues or on peripheral blood basophils. After re-exposure, allergens cross-link to mast 
cell bound specific IgE, causing the activation of cellular signaling pathways, which 
subsequently trigger the release of preformed mediators, such as histamine, the synthesis 
of prostaglandins (PGs) and leukotrienes (LTs), and the transcription of cytokines by 
mast cells [6]. These mediators cause the so-called EAR,  
The EAR is characterized by constriction of airway smooth muscle cells, vascular 
leakage, mucus production, enhanced AHR and recruitment of inflammatory cells [7]. 
The EAR occurs almost immediately, lasting for 30–60 min and 4–12 h later followed by 
LAR [8].  
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The LAR is characterized by excessive inflammation of the airways. The 
inflammatory molecules are produced by various cell types, such as eosinophils, 
neutrophils, T cells, macrophages, dendritic cells, and structural cells. Chronic 
inflammation leads to structural changes in the airways, including airway wall thickening, 
subepithelial fibrosis, goblet cell hyperplasia, myofibroblast hyperplasia, airway smooth 
muscle cell hyperplasia and hypertrophy, and epithelial hypertrophy [9]. These are 
collectively known as airway remodeling. 
 
An animal model of allergic asthma 
Animal models of asthma have been developed in various animal species. Rat has 
been shown to have several advantages as a model for asthma compared to other species 
[10, 11]. For example, the layers of the submucosal and bronchial muscle are thicker in 
rats compare to mice. The blood supply of bronchial mucosa in rat comes from the 
bronchial artery, which is similar to human. The lamina propria of bronchi in rats 
contains capillaries and veins in contrast to mice, which is a very important feature for 
the development of airway inflammation since these vessels are the exit site of leukocytes 
leading to mucosal inflammation and epithelial damage in asthma in humans and other 
species. Adhesion molecules are expressed in lamina propria after allergen exposure in 
human biopsy specimens. A swelling of the bronchi mucosa, possibly due to dilation of 
bronchial blood vessels, followed by congestion and edema, has often been described in 
fetal asthma. Thus, these anatomical features of the proprietary bronchial mucosa in rats 
are very similar to those in humans.  The rat asthma model also has other similarities with 
human asthma such as the production of IgE in response to allergens, the accumulation of 
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lymphocytes and eosinophils in the lung lavage and tissue, and the characteristic 
elevation of TH2 cytokines. Taken together, rat is considered a good model to study 
human asthma [10]. 
Brown-Norway (BN) rats represent a TH2-like immunophenotype and have been 
established as a “classic” animal model of allergic asthma [12-14], because many of the 
pathological features of human asthma are seen in this model after antigen challenges, 
including the presence of eosinophilic lung inflammation during LAR, damage to the 
airway epithelium, thickening of basement membrane, early and late phase airway 
responses, and the presence of AHR. It is also known that BN rats have more pronounced 
IgE production and inflammatory responses to challenge following sensitization 
compared with other strains [15]. These features of sensitized BN rats provide a good 
model in which to investigate the mechanisms of human asthma. 
 
Bronchopulmonary sensory afferents 
Vagus nerve supplies most of the sensory nerve fibers to the airways and lung. Cell 
bodies of these afferent fibers reside in the nodose and jugular ganglia, projecting 
centrally to the nucleus tractus solitarius, thus relaying the information from the lung and 
airways to the medullar respiratory center.  
There are three major types of sensory receptors in vagus bronchopulmonary 
afferents. 
1) Slowly adapting pulmonary receptors (SARs): myelinated afferents in vagus 
nerve that have a fast conduction velocity. The discharge pattern of SARs is 
synchronized with respiratory cycles. Their activities are closely related to the degree 
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of lung inflation, with a low volume threshold; they are inhibited by deflation and 
adapt slowly to maintained lung inflation. Activation of SARs causes the relaxation 
of airway smooth muscle, shortens inspiration and prolongs expiration. Thus, these 
nerves are responsible for the Hering-Breuer inflation reflex, which inhibits sustained 
inspiratory activity. They also lead to a reflex bronchodilation by inhibiting vagal 
tone. The evidence that SARs can be activated by reflex-induced or drug (such as 
histamine and acetylcholine)-induced smooth muscle contraction suggests that the 
location of these receptors is in the vicinity of airway smooth muscle. Although SARs 
are generally considered as a mechano-sensitive receptor and less sensitive to 
chemical stimulants, their activity can be inhibited by CO2, and may be stimulated by 
volatile anesthetics such as halothanes [16].  
 
2) Rapidly adapting pulmonary receptors (RARs): receptors whose activities are 
generated in myelinated nerves. The sensory terminals of RARs are believed to lie 
under the airway epithelium. RARs respond with a rapidly adapting discharge to a 
maintained lung inflation. The majority of RARs are consistently stimulated by 
deflation of the lung (below the resting lung volume), and thus they were also named 
“deflation receptor”. RARs have a wide range of physiological properties.  Those in 
the nasopharynx, and many in the trachea discharge only during the application and 
removal of a mechanical stimulus. They are usually silent in eupnea and are 
extremely sensitive to mechanical stimuli, but are not very sensitive to the direct 
application of chemical agents. RARs in the larynx and the trachea are very sensitive 
to particulate irritants (cigarette smoke, dust), and, therefore, have been termed the 
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“cough receptor”. Intrapulmonary RARs can be stimulated by gases such as ammonia, 
sulfur dioxide and ozone and also by histamine, or serotonin. Generally, stimulation 
of RARs causes cough, augmented breath and the expiration reflex [17-19].  
 
3) Vagal bronchopulmonary C-fibers: they represent more than 75% of sensory 
nerves innervating the entire respiratory tract including larynx, trachea, bronchial, 
bronchioles and lung [20]. The sensory terminals of these non-myelinated afferents 
are usually located either underneath or between airway epithelial cells [21, 22]. 
These afferents are relatively insensitive to mechanical stimuli, but are extremely 
sensitive to chemical stimuli including inhaled irritants such as acid aerosol, capsaicin, 
and endogenous mediators, such as bradykinin and prostaglandins, released during 
tissue inflammatory and allergic reactions [23, 24].  
The afferent activity arising from these C-fiber endings plays an important role in 
regulating respiratory and cardiovascular function under both normal and abnormal 
physiologic conditions [23]. The primary function of these neurons under normal 
physiological conditions is protective: when the sensory terminals are activated by 
irritants or circulated autacoids, action potentials are conducted through the vagus 
nerves to the commissural subnucleus of the nucleus tractus solitarius and elicit the 
pulmonary chemoreflex that includes apnea, bronchoconstriction, mucus secretion, 
cough, bradycardia and hypotension. These responses limit further infiltration of the 
irritants deeper into the lung. Under certain pathological states, however, these 
afferent nerves develop hypersensitivity, and exaggerated reflex responses become 
deleterious to normal airway function [23, 25]. Activation of C-fiber sensory nerves 
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may release neuropeptides such as substance P (SP), neurokinin A (NKA) and 
calcitonin gene-related peptide (CGRP), which are known to act on a number of 
effector cells in the respiratory tract (e.g., airway and vascular smooth muscles, 
cholinergic ganglia, inflammatory cells and mucous glands), and cause 
bronchoconstriction, protein extravasation, airway mucosal edema and inflammatory 
cell chemotaxis. These reactions are known as “neurogenic inflammation”[26] . There 
is a close relationship between asthma and neurogenic inflammation (Fig. 1.1). In 
asthma, damage to airway epithelium, possibly caused by eosinophil products, 
exposes C-fiber afferent nerve endings. Stimulation of these endings by inflammatory 
mediators such as bradykinin may result in an axon (local) reflex and release of 
sensory neuropeptides [27]. Studies on human airways suggest an increased synthesis 
of SP in the airways of asthmatic patients [28]. The augmented bronchoconstrictive 
effect caused by allergen challenge can be attenuated by the deletion of the 
neuropeptide stored in these sensory nerves in guinea pigs [29, 30]. 
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Fig. 1.1. Neurogenic inflammation in asthmatic airways due to retrograde release of 
peptides from sensory nerves via axon reflex. (Modified from Barnes, 2001) 
SP causes vasodilatation, plasma exudation and mucus secretion. NKA causes 
bronchoconstriction, enhanced cholinergic reflexes, and CGRP vasodilatation.  
  
Afferent nerve fibers can also be classified anatomically by the location of their 
cell bodies. The nodose and jugular ganglia have distinct embryological origins. The 
nodose ganglion is derived from placodes, while the jugular ganglion is derived from 
cells of the neural crest [31]. It is therefore not surprising that there are different 
phenotypes of afferents arising from these two ganglia. In the guinea pig airways, the 
jugular ganglia contain the cell bodies of myelinated Aδ and unmyelinated C-fibers. The 
C-fibers rising from jugular ganglion neurons innervate both the extrapulmonary airways 
(larynx, trachea and bronchus) and the lung parenchymal tissue. The myelinated fibers 
from jugular ganglion have a lower threshold to mechanical stimuli and respond 
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vigorously to classic nociceptive fiber-selective stimuli such as capsaicin and bradykinin. 
In comparison, myelinated afferents from nodose ganglia are exquisitely sensitive to 
punctate mechanical stimuli but respond poorly to stretch, and do not respond to a variety 
of chemical stimuli including capsaicin and bradykinin. In addition, neural crest-derived 
C-fibers innervating the pulmonary system are more likely to express neuropeptides  such 
as SP and CGRP than those derived from placodes [31, 32].  
 
Transient receptor potential vanilloid type 1 ion channel 
One prominent feature of pulmonary C-fibers is the expression of transient receptor 
potential vanilloid type 1 (TRPV1) channels, a member of transient receptor potential 
vanilloid (TRPV) channel family, at the sensory terminal [33]. TRPV1 was first cloned 
from rodent dorsal root ganglion (DRG) neurons  [34] and is a ligand-gated, nonspecific 
cation channel with six transmembrane domains (Fig. 1.2) [35]. TRPV1, a 426 (in the rat) 
amino acid protein [34], is uniquely sensitive to vanilloid molecules including capsaicin, 
the pungent component in the hot pepper, and is also activated by low extracellular pH 
(pH 6–5) [36, 37], elevated concentrations (in the micromolar range) of the 
endocannabionoid, anandamide [38], the lipoxygenase metabolites of arachidonic acid, 
leukotriene B4 (LTB4) or 12-hydroperoxyeicosatetraenoic acids (12-HPETE) [39] and N-
arachidonoyl-dopamine [40]. In addition, TRPV1 is a thermosensor, activated by 
moderate noxious temperature between 42 and 53°C [34]. A recent study in our labs has 
further demonstrated that the TRPV1 expressed in pulmonary-sensory neurons has a 
lower temperature threshold for activation (~39°C) [41]. 
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The expression of TRPV1 is very broad in both neuronal and non-neuronal tissues 
such as DRG, the keratinocytes of epidermis, and bladder [42-44]. The presence of 
TRPV1 has also been confirmed in human airways, mainly in non-myelinated sensory 
nerves from the vagal ganglia [45-47]. Activation of TRPV1 channels on airway sensory 
nerves induces Ca2+ influx into the neuronal cell, membrane depolarization and action 
potentials. Therefore, activation of these non-myelinated vagal sensory terminals in the 
airways can elicit extensive reflex responses mediated through cholinergic pathway and 
axon reflex [48], and trigger the release of neuropeptides from both peripheral and central 
nerve terminals [49].  
The expression of mRNA and protein as well as function of the TRPV1 channel in 
neurons can undergo marked plasticity upon the action of a series of regulatory and 
inflammatory mediators (Fig. 1.2) [50]. For instance, nerve growth factor (NGF) 
increases TRPV1 protein transportation to the peripheral endings of sensory neurons, a 
phenomenon associated with an increase in heat hypersensitivity via a p38 mitogen-
activated protein (MAP) kinase [51]. Protein kinases (PK) A and C, and phospholipase A 
and C metabolites can also modulate TRPV1 function. The threshold temperature for 
TRPV1 stimulation is lowered by anandamide through a PKC dependent pathway [52]. 
The major proinflammatory peptide, bradykinin via activation of the B2 receptor, 
sensitizes TRPV1 by different intracellular mechanisms, including PKC-ε [52, 53], 
displacement of phosphinositide-4,5-bisphosphate (PIP2) from TRPV1 binding [54], and 
12- and 5-lipoxygenase metabolites production [55, 56]. A recent study shows that PGE2 
can sensitize TRPV1 channels through EP1 prostanoid receptors, predominantly through 
a PKC-dependent pathway in mouse DRG neurons. The temperature threshold for 
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TRPV1 channel activation was reduced to below 35°C after PGE2 treatment [57]. Our lab 
has shown that PGE2 activates the Gs protein-coupled EP2 prostanoid receptor present on 
the membrane of vagal sensory neurons. Then, the stimulation of PKA by the increase in 
cyclic AMP (cAMP) increases the phosphorylation of TRPV1 and enhances its 
excitability [58].  
Extensive evidence has suggested a potential involvement of TRPV1 channels in the 
pathogenesis of asthma. Endogenous TRPV1 activators, such as hydrogen ion and 
lipoxygenase products, have been detected in asthmatic patients [59, 60]. In allergic 
animal models, pre-treatment with capsaicin to degenerate the airway TRPV1-expressing 
afferents and to deplete sensory neuropeptides, inhibits allergen-induced airway 
constriction in sensitized guinea pigs [29] and AHR in allergic rabbits [61], suggesting an 
important role for these airway sensory nerves. In a mouse model of non-atopic asthma, 
dinitrofluorobenzene sensitization and challenge induces an accumulation of 
inflammatory cells and AHR; these responses can also be inhibited by capsaicin 
pretreatment [62]. Recent studies have further presented convincing evidence of an 
important role of TRPV1 in the manifestation of various symptoms of airway 
hypersensitivity associated with airway inflammation [63]; for example, bronchomotor 
response and cough sensitivity to TRPV1 activators, capsaicin or citric acid aerosol, are 
markedly elevated in patients with asthma or airway inflammation [64, 65]. One of the 
most prominent pathophysiological features of asthma is bronchial hyperresponsiveness 
[66], which is generally believed to be closely associated with endogenous release of 
various chemical mediators from inflammatory cells. Recent studies have demonstrated 
that some of these inflammatory mediators (e.g., prostaglandins, bradykinin, leukotrienes, 
 
 12  
eosinophil granule-derived cationic proteins, etc.) can markedly enhance the sensitivity of 
TRPV1 and lower its threshold for activation (Fig. 1.2) [67]. Furthermore, a recent report 
has further revealed a higher tissue temperature in the airways of asthmatic patients [68]. 
Thus, a given level of stimulation may evoke a greater afferent discharge of the TRPV1-
expressing C-fiber endings and consequently a more severe bronchoconstriction via both 
the central cholinergic pathway and  local axon reflex [67] . 
 
Fig. 1.2. TRPV1 is a transducer and an integrator of nociceptive stimuli. (Modified 
from Cortight and Szallasi, 2004) 
TRPV1 is directly activated by a multiplicity including vanilloids (capsaicin), low pH, 
elevated temperature, and arachidonic acid. TRPV1 is indirectly activated through the 
protein kinase-mediated signaling pathways by activation of prostaglandin and 
bradykinin receptors. 
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1.2 Rationale and Hypothesis 
Asthma is characterized by airway inflammation and AHR in response to a 
number of bronchoconstrictive stimuli, but the precise mechanism is not clear. AHR 
induced by allergen sensitization can be divided into 2 distinct phases, early and late, 
based on the timing of the response in relation to antigen exposure. The EAR, which is 
due to the contraction of airway smooth muscles induced by the degranulation of mast 
cells, occurs within minutes after inhalation of antigen, lasts up to an hour, and is 
followed by a rapid return to baseline. The LAR then emerges in 4 to 12 hours after 
antigen exposure and may persist for more than 24 hours. There is an accumulation of 
inflammatory cells, especially eosinophils, in the airways.  These inflammatory cells 
cause further tissue damage. Previous studies show that bronchopulmonary capsaicin-
sensitive afferent fibers (C-fibers) are involved in the development of  AHR in asthma 
[30, 69]. Endogenous inflammatory mediators released during the allergic reactions can 
modulate the excitability of primary C-fiber afferents [70]. Tachykinins such as SP 
released from C-fibers are believed to play a part in airway hyperreactivity in guinea pigs. 
Enhanced pulmonary C-fiber activity and airway responsiveness to inhaled cigarette 
smoke have been observed in ovalbumin (Ova) -sensitized guinea-pigs. In addition, the 
excitability of myelinated afferents has been shown to increase during the development of 
asthma. Antigen can induce the increased excitability of Aδ myelinated afferents in 
isolated guinea pig airways [71]. Challenging the isolated bronchus with a sensitizing 
antigen resulted in a transient depolarization of the resting membrane potential of the 
guinea pig sensory ganglion [72]. The inflammatory mediators such as NGF can induce 
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neuropeptide production in rapidly adapting afferent nerves that do not normally express 
these peptides [73]. NGF increased the capsaicin sensitivity of sensory neurons both in 
vivo and in vitro [74-77]. Capsaicin is a potent stimulant of pulmonary C-fibers and a 
specific agonist of TRPV1 channels. The presence of TRPV1 has been demonstrated in 
human airways, mainly in the sensory nerves originating from the vagal ganglia [45-47]. 
Increased sensitivity of pulmonary C-fibers to capsaicin has been reported in asthmatics 
[78]. Activation of TRPV1 in sensory nerves leads to neurotransmitter release from 
peripheral and central nerve endings resulting in neurogenic inflammatory 
bronchoconstriction, mucus hypersecretion and cough [79, 80]. However, the role of 
TRPV1 and the relative involvements of different types of bronchopulmonary afferents in 
the allergen-induced chronic airway inflammation are not clearly defined.  
 
Hypothesis: Sensitivity of bronchopulmonary afferents is altered during allergen-
induced airway inflammation, and an increase in the sensitivity and/or expression of 
TRPV1 channels in these sensory neurons is involved. The main objective of these 
studies is to test this hypothesis in a well-established animal model of asthma. 
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CHAPTER TWO 
 
Study Series 1: 
Sensitizing Effects of Chronic Exposure and Acute Inhalation of Ovalbumin Aerosol 
on Pulmonary C-fibers in Rats 
 
2.1 Specific Aim 
This study was carried out in an animal model of allergen-induced asthma to 
investigate: 1) whether the excitability of pulmonary C-fibers in response to mechanical 
and chemical stimuli was altered in rats that were sensitized with Ova; and 2) if so, 
whether the responses were altered by acute Ova inhalation challenge in sensitized rats. 
 
2.2 Methods 
The experimental procedures in study series 1 were performed in accordance with 
the recommendations of the Guide for the Care and Use of Laboratory Animals, 
published by the National Institutes of Health, and were also approved by the University 
of Kentucky Institutional Animal Care and Use Committee. 
 
Animal Sensitization and Allergen Exposure  
Pathogen-free male BN rats weighing 250-350 g were divided into two groups 
(control and sensitized). Sensitized rats received an initial intraperitoneal (i.p.) injection 
of a suspension containing 2 mg Ova in 1 ml Imject Alum as adjuvant. Three days after 
the initial intraperitoneal injection, sensitized rats were exposed to Ova aerosol for 15 
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min each time, 3 times per week for 3 weeks, following the protocol established by 
previous investigators [81]. During exposure, the unanesthetized rat was placed in a 
Plexiglas restrainer (University of Kentucky, Center for Manufacturing), and breathed 
spontaneously and continuously through a nose cone connected to a free stream of 
air/aerosol mixture under a negative-pressure exhaust hood (Fig. 2.1). The Ova solution 
(wt/vol concentration: 1.25% in saline) was nebulized and delivered by an ultrasonic 
nebulizer (Model 099HD; Devilbiss) at a droplet size ranging from 0.5 to 5 µm. Control 
rats received the i.p. injection and aerosol inhalation of the vehicle (isotonic saline) 
following the identical procedures. 
 
Animal Preparation 
After 3 weeks of either Ova or saline exposure, rats were initially anesthetized with 
an i.p. injection of α-chloralose (100 mg/kg) and urethane (500 mg/kg) dissolved in a 2% 
borax solution; whenever necessary, supplemental doses (one-tenth of the initial dose) of 
the same anesthetics were injected intravenously (i.v.) to maintain abolition of pain 
reflexes elicited by paw-pinch. The right femoral artery and the left jugular vein were 
cannulated for recording arterial blood pressure (ABP) and administration of 
pharmacological agents, respectively; the latter was advanced until its tip was positioned 
just above the right atrium. A short tracheal cannula was inserted just below the larynx via 
a tracheotomy. Tracheal pressure (Pt) was measured (MP45-28; Validyne) via a side-port 
of the tracheal cannula. After a midline thoracotomy was performed, the lung was 
artificially ventilated with a respirator (model 7025; UGO Basile), and the expiratory 
outlet of the respirator was placed under 3 cmH2O pressure to maintain a near-normal 
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functional residual capacity. Volume and frequency were set at ~ 8 ml/kg and 48-50 
breaths/min, respectively, to mimic those of unilaterally vagotomized rats. Body 
temperature was maintained at ~ 36°C by means of a heating pad placed under the animal 
lying in a supine position.  
 
Electrophysiological Recording of Pulmonary C-fiber Activity 
Single-unit pulmonary C-fiber activity was recorded as previously described [82]. 
Briefly, the right cervical vagus nerve was separated from the right carotid artery. The 
caudal end of the cut right vagus nerve was placed on a small dissecting platform and 
immersed in a pool of mineral oil. A thin filament was teased away from the desheathed 
nerve trunk and placed on a platinum–iridium hook electrode. Action potentials were 
amplified (P511K; Grass Instruments Co.), monitored by an audio monitor (AM8RS; 
Grass Instruments Co.) and displayed on an oscilloscope (model 2211; Tektronix Inc.). 
The thin filament was further split until the afferent activity arising from a single unit was 
electrically isolated. The nerve trunk was ligated just above the diaphragm to eliminate 
afferent signals arising from lower visceral organs. The afferent activity of a single unit 
was first searched by hyperinflation (3-4 x VT) and then identified by the immediate 
(delay < 1 s) response to a bolus injection of capsaicin (1.0 µg/kg) into the right atrium. 
Finally, the general locations of pulmonary C-fibers were identified by their responses to 
the gentle pressing of the lungs with a blunt-ended glass rod. The signals of the afferent 
activity, Pt and ABP were recorded on a thermal writer (TW11; Gould Instrument 
Systems Inc.) and on a VCR format data recorder (SLV-N900; Sony Electronics Inc.). 
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Fiber activities (FA) in impulses per second (imp/s) were analyzed by an on-line data 
acquisition system (TS-100; Biocybernetics) in 0.5-s intervals.  
 
Inflammatory Cell Analysis in Bronchoalveolar Lavage Fluid (BALF) 
BALF was collected from two other groups of rats (control and Ova-sensitized) after 
3 weeks of vehicle and Ova exposures, respectively. BALF was obtained by injecting 
10 ml of sterile saline (5 ml, twice) into the lungs of the anesthetized rat via a tracheal 
cannula. The collected BALF (approximately 7 ml) was centrifuged at 1,500 rpm for 
10 min, and the pelleted cells were treated with TRIS-buffered ammonium chloride 
solution (pH 7.2) to lyse red blood cells. The remaining cells were washed once with 
phosphate-buffered saline, supplemented with 1% fetal calf serum, 100 U/ml penicillin, 
100 µg/ml streptomycin, and 250 ng/ml amphotericin (GIBCO). Total cell counts were 
determined using a hemocytometer. Differential leukocyte counts were then performed on 
cytospin slides after Wright-Giemsa staining. A minimum of 500 leukocytes were 
counted using standard morphologic criteria and determined by two different individuals. 
The data were then averaged.  
 
Measurements of Lung Mechanics  
Control and sensitized rats were anesthetized and artificially ventilated, in the same 
manner as that described earlier, one day after the last Ova exposure or vehicle. A 
catheter for measuring intrapleural pressure (Ppl) was inserted into the intrapleural cavity 
via a surgical incision between the fifth and sixth ribs; this incision was subsequently 
sutured and further sealed air-tight with silicone jelly. The pneumothorax was then 
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corrected by briefly opening the intrapleural catheter to ambient air during a held 
hyperinflation (3 × VT). During the experiment, animals were paralyzed with 
pancuronium bromide (50 µg/kg, intravenously). Transpulmonary pressure was measured 
as the difference between Pt and Ppl with a differential pressure transducer (Validyne MP 
45-28). Respiratory flow was measured with a heated pneumotachograph and a 
differential pressure transducer (Validyne MP 45-14). All signals were recorded on a 
chart recorder (Grass model 7); total pulmonary resistance (RL) and dynamic lung 
compliance (Cdyn) were analyzed continuously by an on-line computer on a breath-by-
breath basis (TS-100 series; Biocybernetics).  
 
Acute Ova Inhalation Challenge 
Ova aerosol (3%) was delivered directly into the lungs for 5 min; aerosol was 
generated by an ultrasonic nebulizer (Lumiscope 6610; Lumiscope Co.) that was 
connected between the outlet of the respirator and the tracheal cannula to prevent 
contamination of the breathing circuit by the residual Ova. The mass mean diameter of 
aerosol under our experimental setting was estimated to be 3-4 µm. To shorten the 
protocol in order to maintain the signal stability of single-fiber recording, acute inhalation 
Ova challenge was administrated for a shorter duration (5 min) at a higher concentration 
of Ova solution (3%). 
 
Methacholine (MCh) Dose-response Curve  
To verify AHR, responses of RL and Cdyn to inhalation challenge with increasing 
concentrations of MCh aerosol (0.1, 0.3, 1, 3 mg/ml solutions) were determined in each 
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animal. MCh aerosol was generated and delivered in the same manner as described above 
for 1 min. There was a 15-min interval between two consecutive MCh aerosol challenges. 
The lungs were hyperinflated (3 × VT) at 2 min before each MCh aerosol challenge.  
 
Experimental Protocol 
Three series of experiments were carried out. Series 1-1 was carried out to determine 
the presence and severity of airway inflammation by differential leukocyte counts of the 
BALF on day 21 at 4-6 hours after the last inhalation exposure to Ova aerosol.  
Series 1-2 was designed to investigate whether the bronchomotor responses to 
inhaled MCh aerosol and acute Ova inhalation challenge were altered by Ova 
sensitization in anesthetized rats. On day 24, the dose-response curve to MCh aerosol was 
obtained in each of the animals. Subsequently, responses of RL and Cdyn were measured 
continuously in each animal before and for 30 min immediately after acute Ova inhalation 
challenge. 
Series 1-3 was carried out to determine whether the excitability of pulmonary C-
fibers was altered by chronic Ova sensitization, and to determine if the changes were 
further augmented by acute Ova inhalation challenge. The baseline activities and the 
responses to lung inflation and chemical stimulation were determined in anesthetized, 
open-chest, and artificially ventilated rats before and within 45 min after acute Ova 
challenge in both control and sensitized rats on day 24. The baseline FA was recorded 
first followed by the response to lung inflation, and five minutes later the response to 
chemical stimulation. A 10-min interval was allowed between two chemical stimulation 
trials. Baseline FA was averaged over 60 s in each fiber before and 5-15 min after acute 
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Ova challenge (3%, 5 min). Constant-pressure lung inflation was applied by inflating the 
lung with a constant air flow (~ 12 ml/s) until Pt reached 15 or 30 cmH2O, and 
maintained at that pressure for 10 s after turning off the respirator. Two chemical agents 
(capsaicin 0.25 and 0.5 µg/kg; adenosine 75 and 150 µg/kg) were selected as stimulants 
of pulmonary C-fibers for the following reasons: capsaicin is a potent stimulant of 
pulmonary C-fibers and a selective agonist of TRPV1 [34]; adenosine is a metabolite of 
ATP and another pulmonary C-fiber stimulant, but its action is mediated by activating 
adenosine A1 receptors [83]. The volume of each bolus injection was 0.15 ml, which was 
first slowly injected into the catheter (dead space ~ 0.2 ml) and then flushed into the right 
atrium by an injection of 0.4 ml saline before and within 45 min after the acute Ova 
challenge (3%, 5 min). Mean arterial blood pressure (MABP) and heart rate (HR) were 
measured as 30-s averages before and after acute Ova challenge in both control and 
sensitized rats.  
 
Materials 
The Ova solution was prepared daily (concentration = 1.25% in saline). Imject Alum 
as adjuvant was purchased from Pierce Biotechnology (Rockford, IL). A stock solution of 
capsaicin (250 µg/ml) was prepared in 1% Tween 80, 1% ethanol and 98% saline and 
stored at - 20°C. Stock solutions of adenosine (10 mg/ml) and methacholine (250 mg/ml) 
were prepared in saline and stored at - 20°C. Dilutions of these chemical agents at desired 
concentrations for injection or aerosolization were then prepared daily by dilution with 
isotonic saline based on the animal's body weight. All chemical agents were purchased 
from Sigma Chemical. 
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Statistical Analysis  
Data were analyzed with a two-way repeated-measure ANOVA, unless mentioned 
otherwise. One factor was the treatment effect of Ova, and the other factor was the effect 
of lung inflation or chemical agents. When the ANOVA showed a significant interaction, 
pair-wise comparisons were made with a post hoc analysis (Fisher's least significant 
difference). A P-value < 0.05 was considered significant. Data are reported as 
mean ± S.E.M. 
 
2.3 Results 
A total of 52 rats (control, n = 26; sensitized, n = 26) were used in this study. The 
average body weight of control rats (300.8 ± 3.7 g) was significantly higher than 
sensitized rats (279.6 ± 4.4 g; P < 0.05). 
 
Series 1-1: Effect of chronic Ova sensitization on airway inflammatory cells 
infiltration  
The total number of leukocytes in the BALF collected from sensitized rats (n = 7) 
exceeded that of control ones (n = 7) by 73%. In particular, the percentage of eosinophils 
(∆ = 1633%; P < 0.01; paired t-test), neutrophils (∆ = 1159%; P < 0.01), and 
lymphocytes (∆ = 183%; P < 0.05) in the BALF of sensitized rats were distinctly higher 
than that in control rats (Table 2.1).  
 
Series 1-2: Effect of chronic Ova sensitization on bronchial reactivity  
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There was no significant difference in the average baseline RL or Cdyn between 
control and sensitized rats, but the bronchomotor response to acute Ova aerosol challenge 
was significantly higher in sensitized rats (Fig. 2.2). The same Ova inhalation challenge 
evoked an intense increase of the RL, which sustained and remained above the baseline 
for 30 min after challenge in sensitized rats; in contrast, no detectable change in RL was 
found in control rats. The decrease in Cdyn after the Ova inhalation challenge was also 
significantly greater in sensitized rats (Fig. 2.2). Even in control rats, Cdyn decreased 
significantly below the baseline after acute Ova challenge, which was presumably caused 
by the aerosol (liquid) deposition in the lung because the decrease in Cdyn could be readily 
reversed by hyperinflation of the lung (data not shown). 
Inhalation of MCh aerosol induced an increase in RL and a decrease in Cdyn in a dose-
dependent manner in both control and sensitized rats (Fig. 2.3). The bronchomotor 
responses to MCh aerosol were significantly higher in sensitized rats at the higher 
concentrations of MCh (1.0 and 3.0 mg/ml) (Fig. 2.3), verifying the presence of 
nonspecific AHR in the sensitized group. 
 
Series 1-3: Effect of Ova sensitization on the excitability of pulmonary C-fibers 
A total of 35 pulmonary C-fibers were studied in 28 rats (control rats: 311.9 ± 5.7 g, 
n = 14; sensitized rats: 294.4 ± 4.7 g, n = 14). The distribution of these receptors was as 
follows: 2 in upper lobe; 7 in middle lobe; 12 in lower lobe, and 6 in accessory lobe; all 
were located in the right lung. The locations of remaining 8 pulmonary C-fibers were not 
identified, but all of them were activated by lung inflation and a bolus injection of 
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capsaicin with a latency of < 1 s; these receptors were therefore considered as pulmonary 
C-fibers [33]. 
Pulmonary C-fibers showed either no or very low and irregular baseline FA in both 
control and sensitized rats before acute Ova challenge. However, baseline FA in 
sensitized rats (0.36 ± 0.21 imp/s; n = 11) was significantly higher than that in control 
rats (0.02 ± 0.01 imp/s; n = 12, P < 0.05) (Fig. 2.4). After the acute Ova challenge, FA in 
sensitized rats was further elevated (0.74 ± 0.24 imp/s) and significantly higher than that 
in control rats (0.01 ± 0.01 imp/s) (P < 0.01, Fig. 2.4). There was no significant 
difference in FA, compared between before and after acute Ova challenge in either 
control or sensitized rats, despite that the average baseline FA in sensitized rats was 
almost doubled after acute Ova challenge (Fig. 2.4). There was no significant difference 
in either baseline MABP or HR between control and sensitized rats (Table 2.2). 
The pulmonary C-fiber response to lung inflation was also markedly greater in 
sensitized rats. The change in FA (∆FA) in response to lung inflation was calculated as 
the difference between the average FA over the 10-s interval during lung inflation and the 
baseline FA (60-s average) in each fiber. Before acute Ova challenge, the response to 
lung inflation (Pt = 30 cmH2O) in sensitized rats (∆FA = 1.43 ± 0.42 imp/s) was 
significantly higher than that in control rats (∆FA = 0.46 ± 0.1 imp/s, P < 0.05); after 
acute Ova challenge, the same lung inflation evoked a greater response in both groups, 
but the response (∆FA) was greater in sensitized rats (2.83 ± 0.64 imp/s) than in control 
rats (0.85 ± 0.19 imp/s, P < 0.05). The FA response to lung inflation was markedly 
augmented by acute Ova challenge in sensitized rats (P < 0.01), but not in control rats 
(Figs. 2.5 & 2.6). The response to lower intensity of lung inflation (Pt = 15 cmH2O) in 
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sensitized rats was significantly higher than that in control rats after acute Ova challenge, 
but not before the Ova challenge (Fig. 2.6).  
Responses of pulmonary C-fibers to chemical stimulants (capsaicin and adenosine) 
were also clearly elevated in sensitized rats. The ∆FA in response to a stimulus was 
calculated as the difference between the peak FA and the baseline FA (60-s average) in 
each fiber. The peak response of FA was averaged over 2-s and 10-s intervals after 
injections of capsaicin and adenosine, respectively, because the fiber discharges evoked 
by adenosine lasted substantially longer. Right-atrial injection of capsaicin (0.5 µg/kg) 
consistently evoked an abrupt burst of C-fiber activity in both control and sensitized rats, 
accompanied by reflex bradycardia and hypotension, presumably mediated through the 
C-fiber afferents conducted in the left vagus nerve (e.g., Fig. 2.7). The responses of 
pulmonary C-fibers to the high dose (0.5 µg/kg) of capsaicin (∆FA = 12.2 ± 2.3 and 17.5 
± 2.6 imp/s, before and after acute Ova challenge, respectively) in sensitized rats were 
distinctly higher than those in control rats (∆FA = 4.15 ± 0.86 imp/s and 3.81 ± 0.93 
imp/s, before and after acute Ova challenge, respectively; P < 0.05 and P < 0.01) (Figs. 2. 
7, 2.8 & 2.9). In sensitized rats, the duration of discharge in response to capsaicin (0.5 
µg/kg) was also significantly increased after acute Ova challenge (P < 0.01; Fig. 2.9B). 
Interestingly, the decrease in HR and MABP induced by capsaicin appeared to last a 
longer duration after acute Ova challenge in both control and sensitized rats (e.g., Fig. 2.7 
& 2.8). The pulmonary C-fiber response to the lower dose of capsaicin (0.25 µg/kg) was 
also distinctly different between control and sensitized rats, both before and after acute 
Ova challenge. These results further showed that the FA responses to capsaicin were 
significantly augmented by acute Ova challenge in sensitized rats (P < 0.05) (Fig. 2.9), 
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but not in control rats. The differences in response to right-atrial injection of adenosine 
between control and sensitized rats were similar but less pronounced, as compared to the 
difference in the response to capsaicin between the two groups. The response to the high 
dose of adenosine (150 µg/kg) in sensitized rats was higher than that in control rats both 
before and after acute Ova challenge, whereas the response to the low dose (75 µg/kg) 
was significantly higher in the sensitized rats only after acute Ova inhalation challenge (P 
< 0.05) (Fig. 2.10). There was no significant difference in the duration of fiber discharge 
after the adenosine injection either between control and sensitized rats, or before and after 
acute challenge (Fig. 2.10). 
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Table 2.1. Effect of Ova sensitization on leukocyte counts in BALF collected at 4-6 
hours after the acute Ova inhalation challenge. 
 
Data are presented as means ± S.E.M. * (P < 0.05) and * * (P < 0.01), significant 
difference between control and sensitized rats (paired t-test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Group  Total cells 
(×105) 
Basophils
(%) 
Eosinophils
(%) 
Lymphocytes 
(%) 
Monocytes 
(%) 
Neutrophils 
(%) 
Control,  
n = 7 
 
 
12.32±2.89 0.00±0.00 0.26±0.07 4.63±1.03 92.97±1.06 2.20±0.71 
Sensitized, 
n = 7 
 
 
21.46±3.95 0.00±0.00 4.46±0.41** 13.14±2.54* 54.71±8.13* 27.71±8.68**
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Table 2.2. Effects of acute Ova inhalation challenge on average baseline MABP and 
HR in both control and sensitized rats.  
 
 
 
 
 
MABP and HR were measured before and within 45 min after acute Ova challenge (3%, 
5 min). Data are means ± S.E.M.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MABP (mmHg) HR (beats/min)  
Before Ova After Ova Before Ova After Ova 
Control, 
n =14 
86.1±3.3 96.9±3.4 390.3±5.5 386.9±6.0 
Sensitized, 
n =14 
91.3±3.1 102.5±4.5 407.1±6.4 401.3±8.0 
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Figures  
 
 
 
 
Figure 2.1. Experimental setup for exposure of rats to Ova aerosol.  
Panel A:  Photographs show a rat placed in the restrainer during aerosol exposure. Note 
the small dead space in the nose (marked by arrow) which allows the rat to receive 
sufficient Ova/saline aerosol. Panel B: A schematic drawing illustrates the Ova aerosol 
delivery system.  
 
Air 
 
Nebulizer
Ova 5% 
A 
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Figure 2.2. Responses of RL (total pulmonary resistance) and Cdyn (dynamic lung 
compliance) to acute inhalation of Ova aerosol (3%, 5 min).  
Open circles: responses in control animals; filled circles: responses in sensitized animals. 
Ova aerosol (3%; 5 min) was delivered into the lung by respirator between the two 
arrows. The peak responses were averaged over 20 consecutive breaths at every 2 min 
after acute inhalation of Ova in each animal. Data represent means ± S.E.M. of five rats 
in each group. * (P < 0.05), significant difference comparing between the baseline and 
the response to Ova at different time points in either control or sensitized group; † (P < 
0.05), significant difference comparing corresponding data between control and 
sensitized groups. 
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Figure 2.3. Dose responses of RL (total pulmonary resistance) and Cdyn (dynamic 
lung compliance) to aerosolized methacholine (MCh) in control and sensitized rats. 
MCh aerosol was delivered by respirator for 1 min. Peak response to each dose of MCh 
aerosol in each animal was averaged over 10 consecutive breaths that occurred within 30 
seconds after the MCh aerosol exposure (1 min). Baseline data (zero concentration of 
MCh) represent responses to vehicle (isotonic saline). Open circles: responses in control 
animals; filled circles: responses in sensitized animals. Data represent means ± S.E.M. of 
five rats in each group. * (P < 0.05), significant difference comparing the baseline and the 
response to MCh in either control or sensitized group; † (P < 0.05), significant difference 
comparing corresponding data between control and sensitized groups. 
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Figure 2.4. The average baseline fiber activities before and after acute Ova 
challenge in anesthetized, open-chest and artificially ventilated rats.  
Baseline FA was averaged over 60 s in each fiber before and 5–15 min after acute Ova 
inhalation challenge (3%, 5 min). Open bars: control rats, n = 12; close bars: sensitized 
rats, n = 11. * (P < 0.05) and ** (P < 0.01), significantly different between corresponding 
data in control and sensitized rats. Data are mean ± S.E.M. 
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Figure 2.5. Experimental records illustrating the effects of acute Ova challenge on 
the pulmonary C-fiber responses to lung inflation in anesthetized, open-chest and 
artificially ventilated rats.  
Left and right panels, responses to lung inflation (Pt = 30 cmH2O for 10 s) before and at ~ 
15 min after acute Ova challenge (3%, 5 min), respectively. AP, action potential; Pt, 
tracheal pressure; ABP, arterial blood pressure. Receptor location in the control rat (297 
g): right lower lobe. Receptor location in the sensitized rat (298 g): right accessory lobe. 
The large spike at the end of lung inflation in each panel was electrical noise generated 
by turning on the respirator. 
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Figure 2.6. Effect of Ova sensitization on the average responses of pulmonary C-
fibers to lung inflation in anesthetized, open-chest and artificially ventilated rats. 
Left and right panels, average responses to lung inflation at Pt of 15 and 30 cmH2O, 
respectively. Open bars: control rats, n = 13; closed bars: sensitized rats, n = 16 in left 
panel, and n = 15 in right panel. Responses were tested both before and 5-25 min after 
acute Ova challenge (3%, 5 min) in both control and sensitized rats. ∆FA represents the 
difference between the average FA over the 10-s interval during lung inflation and the 
average baseline FA (over 60 s) in each fiber. * (P < 0.05) and ** (P < 0.01), significant 
difference in responses between control and sensitized rats; † (P < 0.05) and †† (P < 
0.01), significant difference in responses between before and after acute Ova challenge in 
either control or sensitized rats. Data are means ± S.E.M. 
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Figure 2.7. Experimental records illustrating the effects of acute Ova inhalation 
challenge on the pulmonary C-fiber responses to capsaicin in anesthetized, open-
chest and artificially ventilated rats. 
 Left panel, responses to capsaicin (0.5 µg/kg in 0.15 ml volume) that was slowly injected 
into the catheter and then flushed (at arrow) into the right atrium as a bolus with saline 
(0.4 ml) before acute Ova challenge (3%, 5 min); right panel, responses to the same dose 
of capsaicin at ~ 30 min after acute Ova inhalation challenge. Receptor location in control 
rat (300 g): right lower lobe. Receptor location in sensitized rat (285 g): right lower lobe. 
For detailed descriptions, see legend of Fig. 2.5. 
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Figure 2.8. Effects of acute Ova inhalation challenge on pulmonary C-fiber activity 
and cardiovascular responses to capsaicin in anesthetized and open-chest rats. 
 Left and right panels: the FA and cardiovascular responses to right-atrial injection of 
capsaicin (0.5 µg/kg) in both control (open circles, n = 13) and sensitized (closed circles, 
n = 15) rats before and 15-30 min after acute Ova challenge (3%, 5 min), respectively. 
MABP, mean arterial blood pressure; HR, heart rate. Dashed vertical line depicts the time 
of capsaicin injection. 
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Figure 2.9.  Effect of Ova sensitization on the average peak response and the 
duration of discharge of pulmonary C-fibers in response to right-atrial bolus 
injection of capsaicin in anesthetized, open-chest and artificially ventilated rats. 
Panel A and B, average peak responses (top) and durations of discharge (bottom) of 
pulmonary C-fibers in response to right-atrial injections of capsaicin at 0.25 and 0.5 
µg/kg, respectively. Open bars: control rats, n = 11 in panel A, n = 13 in panel B; closed 
bars: sensitized rats, n = 10 in panel A, n = 15 in panel B. ∆FA represents the difference 
between the peak FA (average over 2-s interval) within 5 s after the injection and the 
baseline FA (average over 60-s interval) in each fiber. Duration of discharge was 
calculated as the time when FA exceeded the average baseline FA by 1 imp/s. Responses 
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were tested before and 15-30 min after the acute Ova challenge (3%, 5 min) in both 
control and sensitized rats. * (P < 0.05) and ** (P < 0.01), significant difference in the 
response or the duration of discharge between control and sensitized rats; † (P < 0.05) 
and †† (P < 0.01), significant difference in the response or the duration of the discharge 
between before and after acute Ova challenge. Data are means ± S.E.M. 
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Figure 2.10. Effect of Ova sensitization on the average peak response and the 
duration of discharge of pulmonary C-fibers in response to right-atrial bolus 
injection of adenosine in anesthetized, open-chest and artificially ventilated rats. 
Panels A and B, average peak responses (top) and durations of discharge (bottom) of 
pulmonary C-fibers in response to right-atrial injections of adenosine at 75 and 150 µg/kg, 
respectively. Open bars: control rats, n = 12; closed bars: sensitized rats, n = 12. ∆FA 
represents the difference between the peak FA (average over 10-s interval) and the 
baseline FA (average over 60-s interval) in each fiber. Duration of discharge was 
calculated as the time when FA exceeded the average baseline FA by 0.5 imp/s. 
Responses were tested before and 25-45 min after acute Ova challenge (3%, 5 min) in 
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both control and sensitized rats. * (P < 0.05), significant difference in the response 
between control and sensitized rats. Data are means ± S.E.M. 
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CHAPTER THREE 
 
Study Series 2: 
Altered Expression of TRPV1 and Sensitivity to Capsaicin in Pulmonary 
Myelinated Afferents following Chronic Airway Inflammation in the Rat 
 
3.1 Specific Aim 
The present study was carried out to investigate: 1) whether the sensitivity of 
vagal myelinated afferents to capsaicin is altered in Ova-sensitized rats; and 2) If so, 
whether the expression of the TRPV1 channel is upregulated in pulmonary sensory 
neurons of the nodose and jugular ganglia. 
 
3.2 Methods 
The experimental procedures in study series 2 were performed in accordance with 
the recommendations of the Guide for the Care and Use of Laboratory Animals, and were 
also approved by the University of Kentucky Institutional Animal Care and Use 
Committee. 
 
Allergen Sensitization and Animal Exposure  
 
Adult male BN rats were separated into 2 groups (control, n = 19; sensitized, n = 21). 
Sensitized rats received the same sensitization procedure as described in Chapter 2, 
except the concentration of Ova solution was increased to 5% (wt/vol concentration: 5% 
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in saline). Control rats received i.p. injection and aerosol inhalation of the vehicle 
(isotonic saline) following the identical procedures as sensitized rats. 
 
Animal Preparation 
After 3 weeks of either Ova or saline exposure, rats were anesthetized, and trachea, 
femoral artery and left jugular vein were cannulated for measuring Pt, ABP and 
administration of pharmacological agents, respectively. For detailed descriptions of other 
procedures, see Chapter 2. 
 
Measurements of Pulmonary Chemoreflex Responses 
Rats breathed spontaneously via the tracheal cannula. Respiratory flow was 
measured with a heated pneumotachograph connected to the tracheal cannula and a 
differential pressure transducer (Validyne MP45-14), and integrated to give VT. f, 
expiratory duration (TE), ABP, and HR were analyzed (TS-100; Biocybernetics) on a 
breath-by-breath basis by an on-line computer. 
 
Measurement of Single Fiber Activity  
Pulmonary single-unit fiber activities were recorded in anesthetized, vagotomized, 
open-chest and artificially ventilated rats, as described in details in Chapter 2 [33]. Briefly, 
after a midline thoracotomy was performed, the lung was artificially ventilated with a 
respirator (Model 7025; UGO Basile); the expiratory outlet of the respirator was placed 
under 3 cmH2O pressure to maintain a near-normal functional residual capacity. Volume 
and frequency were set at ~8 ml/kg and 48-50 breaths/min, respectively. To prevent a 
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possible indirect stimulatory effect caused by reflex bronchoconstriction on these 
afferents, bilateral vagotomy was performed on these animals. The caudal end of the cut 
right vagus nerve was placed on a small dissecting platform and immersed in a pool of 
mineral oil. A thin filament was teased away from the desheathed nerve trunk and further 
split until the afferent activity arising from a single unit was electrically isolated. The 
nerve trunk was ligated just above the diaphragm to eliminate afferent signals arising 
from lower visceral organs. 
SARs and RARs were searched initially by their responses to lung inflation and 
deflation, and then further identified by their adaptation indexes (AIs) in response to lung 
inflation; AI was calculated in each fiber by dividing the difference in fiber activity (FA) 
between the first two seconds during a constant-pressure (Pt = 30 cmH2O) lung inflation 
by the FA of the first second, and expressed as a percentage [84]. Fibers with AIs of < 
80% and > 80% were classified as SARs and RARs, respectively. The signals of the 
afferent activity, Pt and ABP were recorded on a thermal writer (Gould TW11; Gould 
Instrument Inc.), and analyzed by a computer and a data acquisition system (TS-100; 
Biocybernetics) in 0.1 s intervals. 
 
Measurement of Conduction Velocity 
As described in details previously [33], we isolated the intrathoracic segment of 
the right vagus nerve in each animal, and placed a pair of stimulating electrodes under the 
vagus nerve above the exit of its pulmonary branches. A rectangular constant-current 
pulse (duration: 0.1-0.3 ms; intensity: 0.2-1.0 mA) was generated by a pulse generator 
(WPI A310) and a stimulus isolation unit (WPI A360R-C), and delivered to the 
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stimulatory electrodes. The exact distance between stimulating and recording electrodes 
was measured to calculate the conduction velocity. The general locations of all fibers 
were identified by their responses to gently pressing the lungs with a saline-wetted cotton 
Q-tip. Only receptors with their locations identified in the lung or airways were included 
for data analysis in this study. Finally, animals were euthanized after the experiment by 
an i.v. injection of KCl. 
 
Retrograde Neuronal Tracing 
The cell bodies of sensory neurons innervating the lungs and airways were 
identified by retrograde labeling from the lungs using the fluorescent tracer, 1,1’-
dioctadecyl-3,3,3’,3’-tetramethylindocarbocyanine perchlorate (DiI; Sigma). A 
polyethylene catheter (PE-150) was inserted into the trachea of the anesthetized 
(pentobarbital sodium, i.p., 40 mg/kg) rat via larynx, and its tip was positioned above the 
thoracic inlet. DiI (1 mg/ml) was sonicated and dissolved in ethanol, diluted in saline (1% 
ethanol vol/vol), and instilled into the lungs (0.2 ml x 2) with the animal's head tilted up at 
~30°. Five days later, the rats were subjected to chronic exposure to saline or Ova aerosol. 
 
Tissue preparation 
On day 24 (three days after the last exposure to saline or Ova aerosol), rats were 
anesthetized with halothane inhalation, euthanized and transcardially perfused with 
0.01M phosphate-buffered saline (PBS), followed by freshly prepared 0.01 M phosphate 
buffer (pH 7.4) containing 4% paraformaldehyde. The nodose and jugular ganglia were 
dissected and fixed in 4% paraformaldehyde for 4 hours. The ganglia were incubated in 
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20% sucrose in PBS overnight at 4°C, embedded in Tissue-Tek OCT compound (VWR 
Scientific), and frozen in dry ice for serial cryosectioning at 12 µm on a cryostat 
(Model550; MICROM International GmbH). The sections were mounted on SuperFrost 
Plus slides (Fisher Scientific), and air dried.  
 
Immunohistochemistry  
Tissue sections were first pre-incubated for 1 h at room temperature with 0.01 M 
PBS containing 5% normal donkey serum to block non-specific protein binding sites. 
Then, the sections were incubated in a mixture of 1:500 TRPV1 antibody (rabbit 
polyclonal antibody), or in combination with 1:1000 neurofilament (NF) 160/200 
antibody (mouse monoclonal antibody) overnight at 4°C, which were each diluted in PBS 
containing 5% normal donkey serum and 0.1% Triton X-100. After three 10-min washes 
in PBS, the sections were incubated with a mixture of 1:200 FITC conjugated donkey 
anti-rabbit IgG and 1:200 AMCA conjugated donkey anti-mouse IgG for 1 h at room 
temperature. Finally, the sections were washed again in PBS and mounted in 
Vectorshield (Vector Laboratories). 
The immunoreactivity of each neuron was analyzed using epifluorescence 
microscopy (Zeiss Axiovert 100AV) with appropriate filter combinations. DiI was 
detected with the filter module (wavelengths of 552 nm for excitation and 565 nm for 
emission); FITC (495 nm excitation and 528 nm emission); AMCA (353 nm excitation 
and 440 nm emission). The sections were visualized with an AxioCam MRc color CCD 
camera (Zeiss, Inc.). All images were captured using the same brightness and contrast 
setting. 
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The specificity of the TRPV1 antibody used in this study was tested in two 
separate procedures (Fig. 3.1A & B): 1) applying TRPV1 antibody to the nodose-jugular 
ganglia of TRPV1-null mice (B6.129X1-Trpv1tm1Jul/J; the Jackson Laboratory), and 2) 
neutralizing the primary antibody with a blocking peptide (Neuromics). Ganglia tested 
with either of the two procedures showed no the TRPV1 immunoreactivity. For negative 
controls, primary antibodies were omitted (Fig. 3.1C). At least two slides for each animal 
were prepared to test as negative controls. 
 
Quantitative Analysis 
One nodose and one jugular ganglia were studied in each animal. A total of ~100 
sections were obtained from the entire length of each ganglion (~1.5 mm). To avoid 
double counting of the same neurons, every eighth section (≥ 96 µm apart) was selected 
from serial sections for each ganglion. About 12 sections were analyzed per ganglion in 
each trial. Two regions of interest were captured and analyzed per section at 20x 
magnification. 
Computer-assisted image analysis was used to analyze quantitatively the 
expression of TRPV1 and NF immunoreactivity. Digital images were captured using an 
Axiovert 100AV microscope with a CCD camera (AxioCam MRc color CCD; Zeiss, Inc.) 
interfaced through a Dell Dimensions 4600 computer using Axiovision 4.6 software (Carl 
Zeiss Imaging Systems). The TRPV1, NF and DiI thresholds were set based on their 
densities on the control slides. DiI-labeled, TRPV1-positive and NF-positive neurons 
were counted separately, and co-localizations were determined for each region. The 
proportion of a neuron phenotype in a given population of neurons is expressed in 
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percentage and then averaged for group analysis; for example, the percentage of TRPV1-
positive neurons in pulmonary (DiI-labeled) neurons was determined in each section, and 
averaged for the entire ganglion in each animal. Data were then pooled in each group of 
animals for statistical analysis. 
 
Experimental Design and Protocol 
Three series of experiments were carried out: in Series 2-1, we investigated the 
effect of Ova sensitization on pulmonary chemoreflex sensitivity in anesthetized, 
spontaneously breathing rats. The cardiorespiratory reflex responses to right-atrial 
injection of the same dose of capsaicin (0.5-1.0 µg/kg) were compared between control 
and sensitized rats. To determine the responses mediated through vagal myelinated 
afferents to capsaicin, perineural capsaicin treatment (PNCT) of both cervical vagus 
nerves was applied to selectively block the neural conduction in vagal C-fiber afferents as 
described previously [85]. Briefly, cotton strips soaked in capsaicin solution (250 µg/ml) 
were wrapped around a 2–3 mm segment of the isolated cervical vagus nerves for 30 min. 
The apneic response to right-atrial injection of capsaicin was measured as the ratio 
between apneic duration and baseline TE; apneic duration is the longest TE occurring 
within 5 s after the capsaicin injection.  
In Series 2-2, the effects of Ova sensitization on the baseline FA and the 
responses of RARs and SARs to lung inflation and capsaicin were determined. Baseline 
FA was averaged over 20 consecutive breaths in each fiber. Constant-pressure lung 
inflation was applied by inflating the lung with a constant air flow (~ 12 ml/s) until Pt 
reached 30 cmH2O, and maintained at that pressure for 10 s after turning off the respirator. 
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Responses to lung inflation were calculated as the FA in the first second during lung 
inflation. Capsaicin (0.5 and 1.0 µg/kg) was first injected as a bolus (0.15 ml volume) 
into the catheter (dead space ~ 0.2 ml) and then flushed into the right atrium by an 
injection of 0.3 ml saline. The ∆FA in response to capsaicin was calculated as the 
difference between the peak FA (averaged over 2 consecutive breaths) within 5 s after 
capsaicin injection and the baseline FA (averaged over 20 consecutive breaths) in each 
fiber. To avoid any accumulated effect, at least 10 min elapsed between two injections.  
Series 2-3 was carried out to investigate whether the ratios of TRPV1-positive 
neurons in pulmonary myelinated and non-myelinated neurons have been altered by Ova 
sensitization. NF has been used as the specific marker for identifying myelinated neurons 
[86, 87]. Thus, DiI-labeled NF-positive neurons were considered as pulmonary 
myelinated neurons. The number of pulmonary non-myelinated neurons (DiI-labeled NF-
negative) was calculated as the number of pulmonary neurons (DiI-labeled) minus the 
number of pulmonary myelinated neurons (DiI-labeled NF-positive).  
 
Materials 
Solution of Ova was prepared daily at the concentration described earlier. Solutions 
of chemical agents at the desired concentrations for injection or aerosolization were 
prepared daily by dilution with isotonic saline based on the animal's body weight. All 
chemical agents were purchased from Sigma Chemical, except Imject Alum (Pierce 
Biotechnology); rabbit polyclonal TRPV1 antibody (Chemicon Inc); FITC conjugated 
donkey anti-rabbit IgG, AMCA conjugated donkey anti-mouse IgG and normal donkey 
serum (Jackson ImmunoResearch Labs). 
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Statistical Analysis 
Statistical analysis of the difference in the responses between control and 
sensitized groups was performed using one-way or two-way ANOVA. When the two-
way ANOVA showed a significant interaction, pairwise comparisons were made with a 
post hoc analysis (Fisher's least significant difference). A P-value < 0.05 was considered 
significant. Data were reported as mean ± S.E.M. 
 
 
3.3 Results 
A total of 40 adult male BN rats were used in this study. Average body weight of 
sensitized rats was significantly lower (266.7 ± 5.5 g; n = 21) than that of control rats 
(300.4 ± 5.6 g; n = 19, P < 0.01). 
 
Series 2-1:  Effect of chronic Ova sensitization on reflex responses induced by 
activation of pulmonary C-fibers and RARs 
 In anesthetized, spontaneously breathing rats, right-atrial injection of capsaicin 
(0.5-1.0 µg/kg) immediately elicited apnea, bradycardia and hypotension in control rats; 
these “pulmonary chemoreflex” responses are well documented in the literature and 
known to be mediated through stimulation of pulmonary C-fiber afferents [23, 48]. In 
comparison, the same dose of capsaicin challenge elicited clearly more pronounced 
pulmonary chemoreflex responses in Ova-sensitized rats (e.g., Fig. 3.2). The apneic ratio 
(apneic duration /average baseline TE) was 265 ± 88 % in control rats (n = 7), and 605 ± 
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193 % in sensitized rats (n = 7; P < 0.05) after injection of low dose of capsaicin (0.5 
µg/kg). More importantly, capsaicin injection frequently elicited an augmented breath 
(inspiratory VT exceeding the baseline VT by twofold), which usually occurred shortly 
following the initial apnea in sensitized rats, but not in control rats (e.g., Fig. 3.2). 
Augmented breath is a vagal-mediated reflex response known to be triggered by 
activation of RARs [88, 89] and can be completely eliminated by vagotomy (data not 
shown). Furthermore, after the C-fiber conduction was selectively blocked by PNCT of 
both cervical vagus nerves, the same capsaicin injection no longer elicited the apnea, 
whereas the occurrence of augmented breath became more consistent and its volume was 
further amplified in sensitized rats (Fig. 3.2), probably resulting from the removal of C-
fiber mediated respiratory inhibition by PNCT [88]. Results of this series imply that 
sensitivity to capsaicin of RARs was elevated in Ova-sensitized rats. 
 
Series 2-2: Effect of Ova sensitization on the excitability of myelinated afferents  
 A total of 75 vagal  bronchopulmonary afferents were studied in 18 anesthetized, 
open-chest rats (18 RARs and 13 SARs in 8 control rats and 26 RARs and 18 SARs in  
10 sensitized rats): in control rats, 9.6, 41.9, 38.6 and 12.9% receptors were in upper, 
middle, lower and accessory lobes, respectively; in sensitized rats, 17.8, 46.7, 28.9 and 
6.6% receptors were in upper, middle, lower and accessory lobes, respectively. The 
average conduction velocities were 12.6 ± 1.5 m/s for RARs and 14.8 ± 2.0 m/s for SARs 
in the control group, and were 13.2 ± 1.5 m/s for RARs and 15.2 ± 1.7 m/s for SARs in 
the sensitized group; no significant difference in the conduction velocity was found 
between control and sensitized rats in either RARs or SARs. 
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Approximately a half of the RARs exhibited distinct phasic baseline activity that 
was synchronous with either expiratory or inspiratory phase of respiratory cycles. The 
remaining RARs had no detectable or very little respiratory-related baseline activity (Fig. 
3.3). These two types of RARs were named as phasic RARs and silent RARs in this study; 
in order to balance the distribution, the same number of each of these two types of RARs 
was selected from both control and sensitized groups for this study. In phasic RAR 
groups, there was no significant difference in the intensity and pattern of the baseline 
activity between control (3.7 ± 1.8 impulses/breath (imp/breath), n = 9) and sensitized 
rats (6.2 ± 1.7 imp/breath, n = 13) (Fig. 3.4). Similarly, in silent RAR groups, there was 
also no significant difference in the baseline activity between control (0.2 ± 0.1 
imp/breath, n = 9) and sensitized rats (0.3 ± 0.1 imp/breath, n = 13). When constant-
pressure lung inflation (Pt = 30 cmH2O) was applied for 10 s, the discharge in RARs 
increased abruptly in response to inflation and then rapidly declined despite the 
maintained Pt (Fig. 3.3). When lung deflation was applied by exposing the expiratory 
outlet of the respirator to atmospheric pressure (Pt = 0 cmH2O), the activity of RARs 
increased and did not show any sign of rapid adaptation during the prolonged deflation 
(e.g., Fig. 3.3). In phasic RARs, the FA in response to lung inflation in the first second 
were 4.4 ± 1.6 and 15.5 ± 5.7 impulses in control (n = 9) and sensitized rats (n = 13) (Fig. 
3.5), respectively, but there was no significant difference between them (P = 0.13). In 
view of the three-fold difference in the responses and  the small sample size of these data, a 
non-parametric statistical analysis (Wilcox rank sum test) was also applied, but a significant 
difference was not found (P = 0.18) in the response. Similarly, in silent RARs, there was 
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also no significant difference in the first-second response to the lung inflation between 
control and sensitized rats (Figs. 3.3 & 3.4).  
In sharp contrast, the responses of these afferents to capsaicin were markedly 
elevated in sensitized rats. In silent RARs, the high dose (1 µg/kg) of capsaicin triggered 
a significantly higher discharge in sensitized rats (∆FA = 3.2 ± 0.9 imp/breath, n = 13) 
than those in control rats (∆FA = 0.5 ± 0.3 imp/breath, n = 9, P < 0.05; Figs. 3.3 & 3.6B). 
The response of phasic RARs to the same dose of capsaicin showed a similar pattern as 
that in silent RARs (Fig. 3.6B; in control rats, ∆FA = 0.9 ± 0.4 imp/breath, n = 9; in 
sensitized rats, ∆FA = 12.4 ± 3.3 imp/breath, n = 13; P < 0.01). 
All of the SARs (13 in control and 18 in sensitized rats) exhibited distinct phasic 
baseline activity that peaked during the inspiratory phase of the respiratory cycles. The 
discharge of SARs showed very little adaptation during the constant-pressure lung 
inflation (AI < 80%), but ceased during deflation (e.g., Fig. 3.5). No significant 
difference in either the baseline activity (FA = 15.8 ± 6.1 imp/breath and 17.8 ± 5.0  
imp/breath in control and sensitized rats, respectively) or the responses to lung inflation 
in the first second (FA = 68.5 ± 11.5 impulses and 86.1 ± 18.0 impulses, in control and 
sensitized rats, respectively) was found between the two groups (Fig. 3.4). In contrast, the 
response to capsaicin (1 µg/kg) was significantly elevated in sensitized rats (∆FA = 8.1 ± 
2.2 imp/breath, n = 18) compared to controls (∆FA = 2.3 ± 1.3 imp/breath, n = 13, P < 
0.05) (Figs. 3.5 & 3.6B).  
When all the pulmonary myelinated afferents, including both RARs and SARs 
were grouped together, right-atrial injection of either low or high dose of capsaicin 
evoked significantly higher responses in sensitized rats than in controls (e.g., at the 
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capsaicin dose of 1.0 µg/kg, ∆FA = 7.9 ± 1.4 imp/breath, n = 44 in sensitized rats, ∆FA = 
1.4 ± 0.7 imp/breath, n = 31 in control rats; P < 0.01; Fig. 3.6A).  
 
Series 2-3: Effect of Ova sensitization on the expression of TRPV1 channels in both 
nodose and jugular ganglia 
To investigate whether TRPV1 expression in pulmonary neurons in nodose and 
jugular ganglia is altered by Ova sensitization, bronchopulmonary neurons were 
identified using DiI labeling. In nodose ganglia obtained from control rats, 35.1% of the 
neurons were retrogradely labeled with DiI, which was similar to that of sensitized rats 
(33.6%). Among these DiI-labeled neurons, 68.1 ± 1.3% exhibited TRPV1 
immunoreactivity in control rats. In comparison, a significantly higher percentage of the 
DiI-labeled neurons (80.9 ± 1.2%; n = 4, P < 0.05) expressed TRPV1 in sensitized rats 
(Fig. 3.7A). To further investigate the relative increase of TRPV1 expression in 
myelinated and non-myelinated neurons, we used NF immunoreactivity as the criterion to 
identify myelinated neurons. Previous studies showed that all NF positive neurons were 
large, myelinated neurons and essentially all NF-negative neurons were small, 
nonmyelinated C neurons [87]. Among these DiI-labeled neurons, 32.8 ± 1.6% and 36.1 
± 2.1% were NF-positive neurons in control and sensitized rats, respectively (Fig. 3.8A). 
The percentage of TRPV1-positive pulmonary myelinated (DiI-labeled and NF-positive) 
neurons was significantly higher in sensitized rats (73.7 ± 1.5%) than in control rats (47.8 
± 1.6%; n = 4, P < 0.05) (Figs. 3.8B & C). Surprisingly, there was no significant 
difference in the percentage of TRPV1-immunoreactive pulmonary nonmyelinated (C-) 
(NF-negative and DiI-labeled) neurons between control (78.1 ± 1.7%) and sensitized rats 
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(85.1 ± 1.5%; n = 4, P > 0.05) (Fig. 3.8B). Thus, the staining for TRPV1 in nodose 
ganglia revealed a substantial increase of TRPV1 expression in DiI-labeled neurons 
induced by sensitization. The increase was mainly found in NF-positive DiI-labeled 
neurons (Table 3.1; Figs. 3.8B & C). 
Among jugular ganglion neurons obtained from the same groups of animals, 
approximately 28.5 ± 0.4% were labeled with DiI in control rats, which was not 
significantly different from those of the jugular neurons in sensitized rats (30.5 ± 1.5%). 
There was no difference in TRPV1 expression in DiI-labeled neurons between control 
and sensitized rats (61.5 ± 3.0% in control rats; 63.8 ± 2.5% in sensitized rats; Fig. 3.7B). 
Furthermore, 31.8 ± 1.8% and 28.5 ± 1.8% of the DiI-labeled neurons in control and 
sensitized rats, respectively, were NF positive (Fig. 3.9A). In contrast to what we found 
in nodose ganglia, the expression of TRPV1 in DiI-labeled NF-positive neurons was not 
different between control and sensitized rats. The percentages of TRPV1-positive 
neurons in bronchopulmonary myelinated neurons were 51.5 ± 1.1% and 47.9 ± 0.6% (P 
> 0.05) in control and sensitized rats, respectively (Fig. 3.9B). Therefore, TRPV1 
expression in either myelinated or non-myelinated neurons was not altered by Ova 
sensitization in jugular ganglia (Table 3.1).  
To avoid possible bias and to verify data accuracy, the quantitative 
immunohistochemistry analyses were re-performed in 21% of the images that were 
randomly selected from both groups and blindly coded by a person unfamiliar with the 
experiment. The difference between the two analyses of the same slides was relatively 
small; for example, the differences for NF, DiI and TRPV1 stainings were 2.1 ± 0.4%, 
4.1 ± 0.8% and 2.6 ± 0.4%, respectively. 
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Table 3.1. Expression of TRPV1-immunoreactivity in myelinated and non-
myelinated pulmonary neurons in nodose and jugular ganglia. 
 
 
Nodose 
(%) 
DiI/All NF(+)/DiI NF(-)/DiI TRPV1(+)/DiI TRPV1(+) 
/DiI NF(+) 
TRPV1(+) 
/DiI NF(-) 
Control 35.1 ± 1.6 32.8 ± 1.6 66.2 ± 1.6 68.1 ± 1.3 47.8 ± 1.6 78.1 ± 1.7 
Sensitized 33.6 ± 2.6 36.1± 2.1 63.9± 2.1 80.9 ± 1.2* 73.7 ± 1.5* 85.1 ± 1.5 
 
 
Jugular 
(%) 
DiI/All NF(+)/DiI NF(-)/DiI TRPV1(+)/DiI TRPV1(+) 
/DiI NF(+) 
TRPV1(+) 
/DiI NF(-) 
Control 28.5 ± 0.4 31.8 ± 1.8 67.2 ± 1.9 61.5 ± 3.0 51.5 ± 1.1 69.9 ± 4.1 
Sensitized 30.5 ± 1.5 28.5 ± 1.8 70.5 ± 1.9 63.8 ± 2.5 47.9 ± 0.6 70.0 ± 3.2 
 
 
The number of DiI-labeled, NF-negative [NF(-)] neurons was calculated by subtracting  
the number of DiI-labeled NF-positive neurons from the total number of DiI-labeled 
neurons; the TRPV1 expression in pulmonary non-myelinated neurons as the number of 
TRPV1-positive DiI-labeled neurons minus the number of TRPV1-postive NF-positive 
neurons with DiI. Control rats, n = 4; sensitized rats, n = 4. Values are means ± S.E.M. *, 
P < 0.05, significant difference between the corresponding data of control and sensitized 
rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56  
Figures  
 
 
Figure 3.1. TRPV1 antibody specificity test (panels A and B) and IHC controls for 
TRPV1 and NF (panel C). 
Panel A demonstrates TRPV1 immunoreactivity (TRPV1-IR) in the ganglion of TRPV1 
wild type (WT) mice, but not in that of TRPV1-/- mice. Panel B demonstrates that 
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preabsorption of the TRPV1 antibody with TRPV1 blocking peptides blocks specific 
binding of the antibody to the tissue with only very low non-specific binding. Panel C 
shows that omitting the primary antibodies (for TRPV1 and NF) incubation step in the 
staining protocol did not result in non-specific binding of the secondary antibodies. Scale 
bar: 100 µm. 
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Figure 3.2. Experimental records illustrating the effect of perineural capsaicin 
treatment (PNCT) of both cervical vagi on cardiorespiratory responses to capsaicin 
injection. 
Upper, middle and lower panels: responses to right-atrial injection of capsaicin before, 
during and after PNCT. Right-atrial injection of capsaicin (1 µg/kg in 0.15-ml volume) 
was slowly injected into the catheter and then flushed (at arrow) into the right atrium as a 
bolus with saline (0.3 ml). Asterisks were added to depict the augmented breaths. Note 
that the augmented breath was consistently elicited by capsaicin in sensitized rat (243 g; 
right) and its volume was amplified when C-fiber conduction in the vagus nerve was 
selectively blocked either during or after PNCT. Vagal-mediated reflex apnea elicited by 
lung inflation (Pt = 10 cmH2O) was not blocked by PNCT in either control or sensitized 
rat (records not shown), indicating that neural conduction was intact in myelinated 
afferents. Partial recovery of the response was shown at 70 min after the termination of 
PNCT in the control rat (257 g; left). Note the augmented breath was always followed 
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immediately by a short apnea (e.g., right lower panel), which was probably caused by the 
hypocapnia generated by the augmented breath. 
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Figure 3.3. Experimental records illustrating the responses of silent RARs to lung 
inflation, deflation and capsaicin injection in anesthetized, vagotomized, open-chest 
and artificially ventilated rats. 
Left, responses to lung inflation (Pt = 30 cmH2O for 10 s); middle, responses to lung 
deflation (Pt = 0 cmH2O at the end of expiration); right, responses to right-atrial injection 
of capsaicin (1 µg/kg; arrow). Note the lack of bradycardia and hypotensive reflex 
responses to capsaicin injection because of the bilateral vagotomy performed in these rats. 
AP, action potential; Pt, tracheal pressure; ABP, arterial blood pressure. Control rat (299 
g): receptor location, right middle lobe; conduction velocity, 15.3 m/s. Sensitized rat (258 
g): receptor location, right lower lobe; conduction velocity, 16.7 m/s. 
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Figure 3.4. Average baseline fiber activities (FA) and the responses of silent (si) 
RARs, phasic (ph) RARs and SARs to lung inflation in anesthetized, vagotomized, 
open-chest and artificially ventilated rats. 
Baseline FA was averaged over 20 consecutive breaths in each fiber. Response to lung 
inflation was measured as the FA during the first second of lung inflation (Pt = 30 
cmH2O). Values are means ± S.E.M. Open bars, control group (n = 9 fibers in A, n = 9 in 
B, n = 13 in C); filled bars, sensitized group (n = 13 fibers in A, n = 13 in B, n =18 in C). 
No statistical difference was found in any of the corresponding data between control and 
sensitized groups. 
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Figure 3.5. Experimental records illustrating the responses of SARs to lung inflation, 
deflation and capsaicin injection in anesthetized, vagotomized, open-chest and 
artificially ventilated rats. 
Left, responses to lung inflation (Pt = 30 cmH2O for 10 s); middle, responses to lung 
deflation (Pt = 0 cmH2O at the end of expiration); right, responses to right-atrial injection 
of capsaicin (1 µg/kg). Control rat (291 g): receptor location, right middle lobe; 
conduction velocity, 12.9 m/s. Sensitized rat (272 g): receptor location, right middle lobe; 
conduction velocity, 16.3 m/s. For detailed descriptions, see legend of Fig. 3.3. 
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Figure 3.6. Effect of Ova sensitization on responses of myelinated afferents to right-
atrial injection of capsaicin in anesthetized, vagotomized, open-chest and artificially 
ventilated rats. 
Panel A: average responses of all the myelinated afferents to right-atrial injection of 
capsaicin at 0.5 µg/kg and 1 µg/kg. Open bars, control group (n = 31 fibers); filled bars, 
sensitized group (n = 44 fibers). Values are means ± S.E.M. ∆FA, difference between the 
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peak FA (averaged over 2 consecutive breaths) within 5 s after capsaicin injection and the 
baseline FA (averaged over 20 consecutive breaths) in each fiber. Panel B: Scatterplot 
diagrams of the responses of silent RARs, phasic RARs and SARs to right-atrial injection 
of capsaicin (1 µg/kg). RAR(si): silent RAR; RAR(ph): phasic RAR. Open circles, data 
obtained in control group (n = 9, 9 and 13 in silent RARs, phasic RARs and SARs, 
respectively); filled circles, sensitized group (n = 13, 13 and 18 in silent RARs, phasic 
RARs and SARs, respectively). Dash line: mean of the ∆FA. *, P < 0.05 and **, P <0.01, 
significant difference in the responses between control and sensitized rats. ††, P < 0.01, 
significant difference in the responses between low and high doses of capsaicin. 
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Figure 3.7. Effect of Ova sensitization on TRPV1 expression in pulmonary neurons 
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in nodose and jugular ganglia. 
Percentages of DiI-labeled (pulmonary) neurons in all neurons, and TRPV1-positive 
neurons in pulmonary neurons in nodose (A) and jugular (B) ganglia. Open bars, average 
data obtained from control rats (n = 4); filled bars, sensitized rats (n = 4). Values are 
means ± S.E.M. *, P < 0.05, significant difference between control and sensitized rats. C 
and D: representative photographs of double-labeling immunohistochemistry of TRPV1 
and DiI in nodose (C) and jugular (D) of both control and sensitized rats. Left, TRPV1 
staining in green; middle, DiI labeling in red; right, the merged image. Arrows are added 
to depict co-localization of TRPV1 staining and DiI labeling in the same neurons. 
Asterisks depict the DiI labeled neurons without TRPV1 staining. Scale bar, 100 µm. 
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Figure 3.8. Effect of Ova sensitization on TRPV1 expression in NF-positive and NF-
negative neurons with DiI labeling in nodose ganglion. 
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A: percentages of NF-positive and NF-negative neurons in DiI-labeled pulmonary 
neurons. B: percentages of TRPV1-positive neurons in NF-positive and NF-negative 
neurons labeled with DiI. Open bars, average data obtained from control rats (n = 4); 
filled bars, sensitized rats (n = 4). Values are means ± S.E.M. *, P < 0.05, significant 
difference between control and sensitized rats. C: representative photographs of triple-
labeling immunohistochemistry of NF, DiI and TRPV1 in nodose ganglia of both control 
and sensitized rats. The first column from left, NF staining in blue; second, DiI labeling 
in red; third, TRPV1 staining in green; fourth, the merged image. Arrows are added to 
depict co-localization of NF staining, DiI labeling and TRPV1 staining in the same 
neurons. Asterisks depict the neuron with co-localization of NF staining and DiI labeling, 
but without TRPV1 staining. Scale bar, 100 µm. 
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Figure 3.9. Effect of Ova sensitization on TRPV1 expression in NF-positive and NF-
negative neurons with DiI labeling in jugular ganglion.  
 
 70  
A: percentages of NF-positive and NF-negative neurons in DiI-labeled (pulmonary) 
neurons. B: percentages of TRPV1-positive neurons in NF-positive and NF-negative 
neurons labeled with DiI. Open bars, average data obtained from control rats (n = 4); 
filled bars, sensitized rats (n = 4). Values are means ± S.E.M. C: representative 
photographs of triple-labeling immunohistochemistry of NF, DiI and TRPV1 in jugular 
ganglia of both control and sensitized rats. For detailed descriptions, see legend of Fig. 3 
8. Scale bar, 100 µm. 
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CHAPTER FOUR 
Discussion and Conclusions 
 
Discussion 
      The first question raised in this dissertation project was whether the sensitivity of 
pulmonary C-fibers is altered by allergen-induced chronic inflammation. The data 
revealed in Chapter 2 showed that baseline activity of pulmonary C-fibers was 
significantly elevated in rats sensitized by chronic inhalation of aerosolized Ova, 
compared to that in control rats. Chronic Ova exposure also produced a distinctly higher 
sensitivity of these afferents to chemical stimulants and lung inflation. The increase in 
fiber sensitivity to capsaicin was demonstrated by pronounced increases in both the peak 
activity and discharge duration in response to the same chemical challenge (Figs. 2.7, 2.8 
& 2.9). In addition, after an acute Ova inhalation challenge, the increase in baseline 
activity and the excitability were further augmented in sensitized rats. In sharp contrast, 
no significant change in the fiber activity or sensitivity was detected in control rats 
following the acute Ova inhalation challenge.  
 
Ovalbumin sensitization-induced airway inflammation and AHR 
Brown-Norway rats have been established as an excellent animal model of allergic 
asthma by previous investigators [12-14]. Many features induced by Ova sensitization are 
very similar to those observed in human allergic asthma, including: production of an 
antigen-specific immunoglobulin (Ig) E antibody; upregulation of T helper 2 cytokines 
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such as interleukin (IL) -4 and IL-5; early and late phase airway responses to the inhaled 
antigen; inflammatory cell (e.g., eosinophils, neutrophils) infiltration; and AHR to non-
specific bronchoactive challenge. In the present study, our data showed a significant and 
sustained increase of airway resistance to acute Ova challenge in sensitized rats, which 
demonstrated the airway hyperreactivity to the antigen challenge (Fig. 2.2). At the same 
time, differential cell counts of the BALF revealed inflammatory cell (eosinophils, 
neutrophils) infiltration in the airways of sensitized animals (Table 2.1). These results are 
therefore in agreement with those reported by previous investigators in the BALF of 
sensitized rats [14] and in the sputum of asthmatic patients during asthmatic attack [90]. 
Furthermore, elevated bronchomotor response to methacholine challenge indicated non-
specific AHR in sensitized rats (Fig. 2.3), which are consistent with those reported by 
previous investigators using the same animal model [14, 91]. 
In Ova-sensitized animals, acute inhalation challenge with aerosolized Ova triggers 
early- and late-phase airway responses in the pattern and time course similar to those 
found in asthmatic patients after acute exposure to allergens [81, 92, 93]. The early-phase 
response, which usually subsides within an hour, is exemplified by severe 
bronchoconstriction, mediated primarily by mast-cell derived mediators including 
histamine and leukotrienes. Four to six hours later, a more sustained late-phase reaction, 
characterized by airway obstruction and inflammatory reaction, develops as a result of 
the action of various endogenous inflammatory mediators, cytokines and chemokines 
generated by the resident inflammatory cells (e.g., mast cells, macrophages and epithelial 
cells) as well as the recruited inflammatory cells (e.g., lymphocytes, neutrophils and 
eosinophils) [66].  
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Inflammatory mediators released from eosinophils and neutrophils  
Extensive evidence suggests a close link of the inflammatory mediators released 
from eosinophils and neutrophils to the airway hypersensitivity developed during allergic 
airway inflammatory reaction. Eosinophils are one of the primary effector cells in airway 
inflammation, and produce a wide range of inflammatory mediators, including granule-
derived cationic proteins such as eosinophil major basic protein (MBP), lipid mediators 
such as prostaglandins and leukotriene C4 (LTC4), and cytokines [94]. Eosinophils may 
also localize to airway nerves by recognizing neuronal adhesion molecules [95], which 
allows the mediators released from esoinophils to act directly on the airway nerves. 
Previous studies demonstrated that activated eosinophils acted directly on DRG neurons 
to stimulate the release of neuropeptides and implicated MBP as a key mediator of this 
direct effect [96]. Recent studies in our lab showed that intratracheal instillation of 
cationic proteins consistently induced intense stimulation and sensitization of pulmonary 
C-fibers, and the cationic charge carried by these proteins is primarily responsible for 
generating the stimulatory and sensitizing effects on pulmonary C-fiber afferents [63, 97, 
98].  
Activated eosinophils can also synthesize and secret newly formed lipid mediators, 
and some of these mediators are known to exert potent sensitizing effects on pulmonary 
C-fibers. For example, PGE2 has been reported to enhance the cough sensitivity to 
capsaicin in healthy human volunteers [99]. Indeed, it has been clearly demonstrated that 
PGE2 can sensitize pulmonary C-fibers in anesthetized rats [100], as well as isolated 
vagal pulmonary sensory neurons [58]. Beside prostaglandins, LTC4, a potent 
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bronchoconstrictor, can also stimulate the release of tachykinins from airway afferent 
nerve fibers in isolated trachea/bronchus of guinea pigs [101].  
Neutrophils are one of the first inflammatory cells to be recruited into the airway 
after an allergen challenge [102, 103]. Neutrophils contain an array of products including 
lipids, cytokines, proteases, microbicidal products, reactive oxygen species (ROS) and 
nitric oxide [104]. Many of these endogenous substances are possible contributors to 
airway hypersensitivity. For example, it has been reported that an airway challenge of 
aerosolized H2O2, one of ROS known to be released in the airways from eosinophils, 
neutrophils and epithelial cells [105], stimulated capsaicin-sensitive vagal pulmonary 
afferents in a dose-dependent manner, and that its sensory transduction was mediated 
through both TRPV1 and P2X receptors [106]. In addition, several cytokines have also 
been suggested to be involved in the sensitization of nociceptors [107]. For example, IL-
1β, IL-6 and tumor necrosis factor α, can be produced by many cell types, including mast 
cells, eosinophils, neutrophils and macrophages in the lung and airways. More recently, 
Yu et al. demonstrated that IL-1β stimulated airway nociceptors in anesthetized rabbits 
[108].  
 
Inflammatory mediators released from mast cells  
After an acute Ova inhalation challenge, the enhanced sensitivity of pulmonary C-
fibers was further augmented in sensitized rats. The increased sensitivity occurred 
coinciding with the period of early-phase response reported previously in sensitized rats 
[93, 109, 110], and mast cell degranulation presumably played a major part of the 
reaction; upon exposure to antigen, IgE binds to the high affinity IgE receptor FcεRI 
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expressed on the mast cells, and triggers the release of mediators such as histamine, 
prostaglandins leukotrienes, and cytokines [111]. Histamine, one of the primary autacoids 
secreted from mast cells, is known to have profound effects on a number of airway cells 
including sensory nerves [111]. A previous study in our lab showed that inhalation of a 
low dose of aerosolized histamine augmented the afferent responses of vagal pulmonary 
C-fibers to both lung inflation and right-atrial injection of capsaicin in anesthetized, 
open-chest dogs [112]. 
Tryptase is frequently considered as a marker of mast cell degranulation [113]. An 
increased concentration of this protease has been found in BALF of asthmatic patients 
[114]. A recent study by Gu and Lee [115] showed that intratracheal instillation of 
trypsin significantly amplified the capsaicin-induced pulmonary chemoreflex responses 
mediated by pulmonary C-fiber afferents. In isolated vagal pulmonary sensory neurons, 
pretreatment with trypsin potentiated the capsaicin-induced whole-cell inward current 
[115], and this effect by trypsin is probably mediated though an activation of protease-
activated receptor-2 (PAR2) and the PKC-dependent transduction pathway. Bradykinin, 
released from mast cells and found in the BALF of asthmatic patients [116], has been 
shown to stimulate bronchial C-fiber afferents in anesthetized dogs [117]. Similarly, in an 
isolated preparation of guinea pig trachea and bronchus, bradykinin activated the C-fiber 
sensory terminals innervating these airways, particularly those originating from the 
jugular ganglia [118]. Bradykinin is also known to increase the sensitivity of C-fibers in 
isolated guinea pig airways and in Ova-sensitized guinea pigs [79, 119]. In addition, 5-
hydroxytryptamine, another autacoid derived from mast cells, stimulated vagal 
bronchopulmonary C-fibers in guinea pig lungs [120]. Together, these studies have 
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provided strong evidence suggesting that these mediators derived from mast cell 
degranulation are probably responsible for the stimulation and sensitization of pulmonary 
C-fibers after acute inhalation challenge with Ova in sensitized rats.  
 
Increased expression and/or sensitivity of TRPV1 in the development of airway 
hypersensitivity 
Our results illustrating the Ova-induced increase in excitability of these C-fiber 
endings to lung inflation have important physiological implications because these endings 
are relatively insensitive to changes in lung volume under normal conditions [33]. 
Furthermore, expansion of the lung is a natural stimulus that occurs commonly in 
physiological conditions; for example, an increase in VT can occur upon taking a deep 
inspiration (sigh) at rest or during hyperventilation in heavy exercise. Activation of 
brochopulmonary C-fibers is known to play a part in evoking the sensation of airway 
irritation, cough and reflex bronchoconstriction [23, 48]. Therefore, the hypersensitivity 
of pulmonary C-fibers to lung inflation may be involved, at least in part, in generating 
these symptoms and airway hypersensitivity found in patients with allergic airway 
inflammation. 
Capsaicin is a potent stimulant of the pulmonary C-fibers and a selective activator of 
the TRPV1 receptor [23, 33, 34, 48]. TRPV1 is a polymodal nociceptive transducer 
containing six transmembrane domains that form non-selective, Ca2+-prefering cation 
channels. TRPV1 is expressed predominantly in non-myelinated neurons, and can be also 
activated by low pH (< 6.0) and high temperature (> 39oC) [34]. Several endogenous 
mediators, such as hydrogen ion, anandamide, and certain lipoxygenase metabolites of 
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arachidonic acid, can also activate TRPV1 expressed in airway sensory nerves [63, 121]. 
The involvement of TRPV1 receptors in the development of airway hypersensitivity in 
asthma has been suggested. For example, patients with asthma are more sensitive to the 
tussive effect of TRPV1 agonists [64]. The sensitivity of capsaicin-induced cough is 
increased in asthmatics [64, 65]. In addition, TRPV1 antagonists can inhibit cough 
elicited by inhalation of Ova aerosol in sensitized guinea pigs [122]. Previous 
investigators have reported increases in the levels of airway acidity, airway temperature 
and lipooxygenase metabolites of arachidonic acid in asthmatic patients [59, 68, 123], all 
of which are known to activate the TRPV1 [124]. Other inflammatory mediators released 
in asthmatic airways (e.g., prostaglandins, bradykinin, etc.) do not activate the TRPV1 
directly, but can lower its activation threshold [63, 121]. The present study further 
demonstrated a distinctly elevated sensitivity of pulmonary C-fibers to capsaicin in Ova-
sensitized rats (Figs. 2.8 & 2.9). Since capsaicin is a selective activator of TRPV1, these 
results seem to suggest a possible involvement of an increase in the response of TRPV1 
channels. I speculate that the enhanced response may have resulted from an increase in 
the expression or excitability of TRPV1, or both, in the sensitized rats. Furthermore, my 
results suggested that other receptors (e.g. adenosine A1 receptors) were also involved in 
the Ova-induced sensitizing effect on pulmonary C-fibers since there were significant 
increases in the C-fiber responses to adenosine and lung inflation in sensitized rats [83], 
and stimulation of C-fibers by neither of these stimuli is known to involve TRPV1 
activation.  
Coincidently, results obtained in the Study Series 2-1 carried out in anesthetized 
and spontaneously breathing rats further revealed a possibility that chronic airway 
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inflammation induced by allergen sensitization might elevate the sensitivity of RARs, 
myelinated vagal afferents, to capsaicin (e.g., Fig. 3.2). In order to test this hypothesis, 
another series of experiments was carried out to answer the second questions: whether the 
sensitivity of vagal myelinated afferents to capsaicin is altered in Ova-sensitized rats and 
whether the expression of the TRPV1 channel is upregulated in pulmonary sensory 
neurons of the nodose and jugular ganglia. 
In Chapter three, experimental data showed that sensitivity to capsaicin of vagal 
bronchopulmonary myelinated afferents, including both RARs and SARs, was 
significantly elevated when chronic inflammation was induced by allergen sensitization 
in rats. Consistent with electrophysiological recording experiments, our 
immunohistochemistry data also showed a significant increase in the proportion of 
TRPV1-expressing bronchopulmonary neurons in nodose ganglia of sensitized rats, 
compared to that of control rats. This increase of TRPV1 expression was found mainly in 
neurofilament-positive neurons (myelinated neurons). Rather surprisingly, we did not 
find any significant difference in the proportion of TRPV1-expressing cells in either 
myelinated or non-myelinated neurons of the jugular ganglia between control and 
sensitized rats.  
 
Over-expression of TRPV1 in pulmonary myelinated afferents  
  RARs are generally recognized as mechanoreceptors in the lung. These receptors 
can be activated by both inflation and deflation of the lung, and a decrease in lung 
compliance and an increase in the interstitial fluid volume in the lung [67, 84, 125]. A 
small percentage of RARs are also sensitive to various inhaled irritants including 
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cigarette smoke, sulfur dioxide and acid [33, 84]. Stimulation of RARs can elicit reflex 
responses such as augmented breath, bronchoconstriction and hypersecretion of mucus. 
In addition, a subgroup of RARs are believed to act as cough receptors in response to 
inhaled irritants [126]. On the other hand, SARs can be activated by volume expansion of 
the lung or an increase in transluminal pressure in the airways [127]. SARs are generally 
considered to be insensitive to capsaicin or any other chemical irritants [33]. The activity 
arising from SARs is known to play an important role in the regulation of breathing 
patterns [17, 18]. Both RARs and SARs are myelinated afferents, as verified by the 
measurement of conduction velocity (> 5 m/s) in each fiber. RARs and SARs were 
classified based upon their adaptation indexes in response to maintained lung inflation at 
30 cmH2O pressure in this study. Similar to that reported in our previous studies [33], the 
heterogeneity of the discharge pattern of both SARs and RARs, and the variability of 
adaptation index in their responses to different inflation pressures are both quite evident. 
A small percentage (~ 20%) of these receptors may fall into the category of “intermediate 
type” [128]. However, this variation in the classification criteria between RARs and 
SARs should not be viewed as a confounding factor in our conclusion because the overall 
response to capsaicin is still markedly greater in the sensitized rats even when the data 
from all myelinated afferents (including both RARs and SARs) were pooled for 
comparison (Fig. 3.6A) 
Capsaicin has been used extensively as a tool for identifying non-myelinated (C-) 
nociceptive afferents in various organ systems [129]. A recent study in our lab showed 
that right-atrial injection of capsaicin stimulated only 6.3% of the RARs and no SARs in 
the lungs of Sprague-Dawley rats [33]. Similar results were also found in the control rats 
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in the present study. However, in stark contrast, right-atrial injection of capsaicin exerted 
a distinct stimulatory effect on RARs and SARs in Ova-sensitized rats. Thus, these 
results demonstrated that chronic airway inflammation induced by Ova sensitization 
triggered a phenotypic switch in myelinated bronchopulmonary afferents and clearly 
upregulated their sensitivity to capsaicin. The results obtained in immunohistochemistry 
experiments further indicate that a high percentage of pulmonary myelinated neurons 
expressed TRPV1 when chronic airway inflammation was induced by allergen 
sensitization. Therefore, it seems reasonable to hypothesize that the overexpression of 
TRPV1 in vagal pulmonary afferents may contribute, at least in part, to the development 
of airway hypersensitivity in allergic airways.   
 
Possibly involvement of neurotrophins  
The mechanisms possibly responsible for the phenotypic change in TRPV1 
expression in pulmonary myelinated neurons are not known. However, neurotrophins 
such as brain-derived neurotrophic factor (BDNF) and NGF should be considered 
because their synthesis and release have been shown to increase in allergic airways [130, 
131]. Furthermore, they are known to upregulate the expression and function of TRPV1 
in sensory neurons [74-76]. For example, it has been suggested that BNDF may 
contribute to the development of hypersensitive airways since mice treated with anti-
BNDF antibodies showed reduced neuronal hypersensitivity to capsaicin [132]. Indeed, 
BDNF can upregulate the capsaicin sensitivity of nodose ganglion cells in culture [76]. 
More importantly, the BDNF serum levels are elevated in asthmatic patients [130]. NGF 
is another important neurotrophic factor to be considered in the pathogenesis of asthma. It 
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has been reported that serum levels of NGF in patients with asthma were positively 
correlated with the severity of the disease [131]. Meanwhile, recent studies have clearly 
demonstrated that NGF can increase capsaicin sensitivity of sensory neurons both in vivo 
and in vitro [74-77], which may be mediated through several possible mechanisms, such 
as increasing the expression of the TRPV1 channel protein [133], promoting translocation 
of the TRPV1 to cell membrane [54], and modulating the TRPV1 function by releasing 
the receptor inhibition from PIP2 [54].  
The relationship between those neurotrophins and the expression of TRPV1 may 
also help to explain another interesting observation in the present study. Increased 
expression of TRPV1 occurred only in nodose pulmonary myelinated neurons, but not in 
their jugular counterparts. Different embryonic origins of these two types of ganglia may 
play a part in causing this difference. Nodose ganglia have a placodal origin, where as 
jugular ganglia arise from the neural crest [32]. It has been suggested that the different 
phenotypes of neurons arising from these two ganglia may be related to different 
requirements in neurotrophic factors. In the chick embryo, placode-derived neurons, such 
as ventrolateral trigeminal neurons [134] and nodose ganglion neurons [135], mainly 
survived and grew in the presence of  BDNF, whereas neural crest-derived neurons, such 
as dorsomedial trigeminal neurons and jugular neurons, were supported preferentially by 
NGF [135]. Meanwhile, BDNF is more abundant in the nodose ganglion than in the 
jugular ganglion [136, 137]. The majority of nodose ganglion neurons expressed tyrosine 
receptor kinase B (TrkB), the preferred receptors for BDNF [45, 138, 139]. Considering 
the observation that the level of BDNF, but not NGF, is likely involved in determining 
the level of capsaicin sensitivity of vagal sensory neurons [76], we suggest that BDNF 
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may be responsible for the inflammation-induced TRPV1 upregulation in nodose ganglia. 
This postulation is further supported by the fact that the majority of small neurons of the 
nodose ganglion express TRPV1 mRNA in conjunction with BDNF receptor TrkB, but 
not NGF receptor TrkA [45]. It has been shown that after nerve injury, small neurons 
(usually C neurons) in DRG switched off their normal syntheses of BDNF, whereas large 
ones (myelinated neurons) switched to a BDNF phenotype [140], which seems also in 
general agreement with our postulation. Taken together, the observations described above 
offer compelling support to our hypothesis that these neurotrophic factors may be 
involved, at least in part, in the over-expression of TRPV1 in myelinated neurons induced 
by allergic airway inflammation. A possible mechanism is that these neurotrophic factors 
induce the activation of MAP kinases pathway (p38, ERK, JNK), which cause 
transcriptional regulation via transcription factors (CREB, ELK-1, Jun), and/or 
translational regulation via translation initiation factors, and finally induce the synthesis 
of TRPV1 channels [141]. Obviously, further investigation is required to test this 
hypothesis. Furthermore, possible contributions to the TRPV1 upregulation by other 
chemical mediators synthesized and released in the airways during the chronic allergic 
inflammation can not be overlooked. 
An allergic inflammation-induced phenotypic change of neuropeptide 
(tachykinins and CGRP) synthesis in sensory nerves has been previously reported in 
guinea pig airways [73]. However, the expression of TRPV1 and neuronal sensitivity to 
capsaicin were not found in the nodose Aδ neurons innervating the trachea and major 
bronchi of Ova-sensitized guinea pigs in that study [73], which is different from our 
observation in this study (Figs. 3.7 & 3.8). Possible causes of this discrepancy are not 
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known, but may be related to several factors such as the severity of the allergic 
inflammation, innervations of different regions of the lung structures, species differences, 
or other unknown factors.  
 
Limitations of immunohistochemistry experiments  
The expression of TRPV1 immunoreactivity was only determined in neuronal cell 
bodies in this study. Therefore, it did not offer any direct evidence of the TRPV1 over-
expression in the sensory terminals of myelinated afferents in sensitized rats. 
Coincidentally, a recent short study reported the number of TRPV1-positive axons in the 
trachea increases in Ova-sensitized guinea pigs [142], which is in general agreement with 
our finding. Furthermore, our data in the in-vivo study indicating that the sensitivities of 
both RARs and SARs to capsaicin were markedly increased in sensitized rats (Figs. 3.3, 
3.5 & 3.6) lend strong support to our conclusion. 
In the present study, we did not find a difference between control and sensitized 
rats in the percentage of pulmonary non-myelinated (NF-negative) neurons that express 
TRPV1 channels. However, we want to emphasize that the contribution of pulmonary C-
fiber afferents in the airway hypersensitivity in this allergic asthma model should not be 
underestimated. Indeed, we have demonstrated that there was an increase in the 
excitability of pulmonary C-fiber to mechanical and chemical stimuli, especially the 
increased sensitivity to capsaicin, in Ova-sensitized rats [143]. Furthermore, we also need 
to point out a limitation in the data analysis of our immunohistochemistry experiments; 
the computer analysis measured only the percentage of bronchopulonary neurons that 
expressed the TRPV1 receptor, rather than the density or the total number of the TRPV1 
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channels expressed in each neuron. Thus, it is very possible that the density and/or the 
sensitivity of TRPV1 channels were elevated in pulmonary non-myelinated neurons of 
sensitized rats, despite a lack of increase in the percentage of TRPV1-expressing neurons. 
In fact, our recent finding in the in-vivo study [143] has offered intriguing evidence for 
such a possibility. Similarly, we can not rule out the possibility that the sensitivity and/or 
density of TRPV1 were also upregulated in the jugular pulmonary neurons in sensitized 
rats.  
 
Altered sensitivities of TRPV1 and other channels and receptors  
Besides the possibility of an increased expression of TRPV1 channels in 
pulmonary afferents, it is also possible that the function and properties of TRPV1 
channels are modified by certain signaling pathways during airway inflammation [50, 
144]. For example, ATP and bradykinin bind to their receptors, which activate PLC. PLC 
can cleave PIP2 to yield inositol-1, 4, 5-trisphosphate (IP3) and diacylglycerol (DAG). 
DAG is upstream signal to PKC which will directly phosphorylate the serine residues 502 
and 800 in TRPV1 protein. At the same time, the hydrolysis of PIP2, a negative regulator 
of TRPV1, will release the inhibition of TRPV1. Thus, activation of intracellular PKC 
activity results in increased TRPV1 sensitivity to capsaicin. The cAMP dependent PKA 
can also directly phosphorylate TRPV1 and increase the excitability of these channels. 
Therefore, the increased phospharylated TRPV1 channels in these afferent nerve 
terminals could be one of the explanations for the increased sensitivity of sensory nerves 
to capsaicin during airway inflammation. Another possibility is that neuromodulators can 
change membrane properties of pulmonary afferents by membrane depolarization and an 
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increase in membrane resistance, which may cause a lower stimulus threshold and an 
increased frequency in action potential [145]. Therefore, the excitability of pulmonary 
afferents to capsaicin is increased. For example, PGE2 and histamine inhibit resting 
potassium “leak” currents, causing an increase in membrane resistance and a gradual 
buildup of cations within the cells, thus producing the minor depolarization. The increase 
in membrane resistance will probably result in an increase in the rate and amplitude of 
action potentials generated by a given a mount of activating stimulus (e.g., mechanical 
perturbation or capsaicin) [145].  
In this thesis, my main focus is on the role of TRPV1 channels in the AHR during 
allergen-induced airway inflammation. However, there are several other channels which 
should not be overlooked in the development of ARH. For example, TRPA1, like TRPV1, 
is expressed in vagal sensory nerves innervating the airways [146, 147] and can be 
regulated by neurotrophic factors, proteases, and certain autacoids such as bradykinin 
[148-150]. TRPA1-selective stimuli can also evoke action potential discharge from 
bronchopulmonary C-fibers and consequent defensive reflexes [147]. TRPV4, found on 
airway smooth muscle cells, might function in the transduction of 
osmolarity/hypotonicity stimuli in airways since hypotonic stimulation induces airway 
constriction in normal and asthmatic airways [121, 151]. Part of the bronchoconstriction 
is probably mediated through cholinergic reflex since hypotonicity stimulates both C-
fiber and rapidly adapting receptors in the airways [121]. Various types of potassium 
channel expressed in airway smooth muscle are also involved in modulation of 
neurotransmitter release from airway nerves [152]. Acid sensing ion channel (ASIC) and 
purinergic receptor subtype X channels (P2Xs) have been suggested to function as 
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transducer for nociceptors [153]. Therefore, it is very important for future studies to 
identify and characterize the properties of these receptors in the development of AHR in 
asthma. 
 
Conclusions  
 The results obtained from these studies are, in most parts, in support of our 
hypothesis. We found that allergen-induced airway inflammation induced a pronounced 
sensitizing effect on vagal pulmonary non-myelinated (C-fiber) afferents and altered 
sensitivity of vagal pulmonary myelinated afferents to capsaicin which is correlated with 
upregualtion of TRPV1 expression in these myelinated neurons.  
These findings should help to improve our understanding of the mechanisms 
underlying the AHR during allergen-induced asthma. These pulmonary afferents have an 
important role in regulating the overall cardiorespiratory function. Both their local axon 
reflexes and centrally mediated reflexes elicited by activation of these afferents are 
expected to be amplified in allergen-sensitized airways, and cause the deleterious effects 
in the respiratory tract during asthma, such as cough, bronchoconstriction, airway 
hypersecretion, bronchial vasodilation and neurogenic inflammation [49]. Therefore, our 
present study suggested that hypersensitivity of pulmonary afferents plays an important 
role in the development and manifestation of AHR induced by allergen sensitization. 
Furthermore, the finding of upregulation of TRPV1 sensitivity and expression in these 
neurons implies that the antagonist of TRPV1 channels may be a potentially effective 
therapeutic treatment for alleviating the allergen-induced AHR. 
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However, there are still many questions that remain unanswered in the present 
study. For example, further studies will be required to evaluate the relative contributions 
of specific types of inflammatory cells and endogenous mediators in the development of 
pulmonary C-fiber hypersensitivity, and to identify the signaling pathways possibly 
involved in the interaction between inflammatory cells and pulmonary C-fiber endings in 
allergen-sensitized airways. In addition, the role of neurotrophic factors in the enhanced 
sensitivity of pulmonary myelinated afferents to capsaicin and upregulation of TRPV1 
channels expression in these nerves remains to be determined. Lastly, we can not 
overlook the possible involvement of an interaction between TRPV1 and other ion 
channels (e.g. TTX-resistant Na+) and/or receptors (e.g., P2X3, etc.) in allergen-induced 
AHR.  It is obvious that mechanisms underlying airway afferent sensitization still need to 
be further investigated in the allergen-induced asthma. 
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APPENDICES 
(LIST OF ABREVIATIONS) 
ABP arterial blood pressure 
AHR  airway hyperresponsivenss 
AIs adaptation index 
AP action potential 
APCs  antigen presenting cells 
ASIC acid sensing ion channel 
BALF bronchoalveolar lavage fluid 
BDNF brain-derived neurotrophic factor 
BN rat  Brown-Norway rat  
cAMP cyclic AMP 
Cdyn dynamic lung compliance 
CGRP calcitonin gene-related peptide 
DRG dorsal root ganglion 
EAR  early-phase asthmatic response 
f frequency 
FA fiber activities 
∆FA the change in fiber activities 
12-HPHETE hydroperoxyeicosatetraenoic acids 
HR heart rate 
Ig  immunoglobumin 
imp/s impulses per second 
 
 89  
i.p. intraperitoneal  
IP3 inositol-1, 4, 5- trisphosphate 
i.v. intravenous 
LAR late-phase asthmatic response 
LTs leukotrienes  
LTB4 leukotriene B4 
TH cells  T helper cells   
MABP mean arterial blood pressure 
MAP major basic protein 
MAP kinase mitogen-activated protein kinase 
MCh methacholine 
NF neurofilament 
NGF nerve growth factor 
Ova ovalbumin 
PAR2 protease-activated receptor-2 
PBS phosphate-buffered saline 
PGs  prostaglandin 
PIP2 phosphinositide-4, 5- bisphosphate  
PK protein kinase 
PNCT perineural capsaicin treatment 
Ppl intrapleural pressure 
Pt tracheal pressure 
RARs rapidly adapting receptors 
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RL  total pulmonary resistance 
ROS reactive oxygen species  
SARs slowly adapting receptors 
SP substance P 
TE expiratory duration 
TRPV transient receptor potential vanilloid type receptor 
TrkB tyrosine receptor kinase B 
VT tidal volume 
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